Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Acquir Immune Defic Syndr
    October 2022
  1. ZHONG M, Chen C, Hu Y, Zou M, et al
    Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  2. YAN D, Wang Z, Wang Y, He S, et al
    Performance of Creatinine- and Cystatin C-Based Equations for Glomerular Filtration Rate Estimation in HIV-1-Infected Individuals Receiving Dolutegravir + Tenofovir Disoproxil Fumarate + Lamivudine as Initial Antiretroviral Therapy: A Retrospective Ob
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  3. LI CL, Liang HY, Xiao J, Li R, et al
    The Effect of Pretreatment Potential Resistance to NNRTIs on Antiviral Therapy in Patients With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  4. NIE J, Zeng Y, Zeng Q, Du X, et al
    Risk Factors for CSF/Plasma HIV-1 RNA Discordance in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  5. ZHAO F, Rao M, Chen W, Cai K, et al
    Dolutegravir Plus Lamivudine Dual-Drug Regimen in Treatment-Naive HIV-1-Infected Patients With High-Level Viral Load: Preliminary Data From the Real World.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  6. SUN L, He Y, Xu L, Zhao F, et al
    Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  7. TONGTONG Y, Shenghua H, Yin W, Lin C, et al
    Effectiveness and Safety of Dolutegravir Versus Efavirenz-Based Antiviral Regimen in People Living With HIV-1 in Sichuan Province of China: A Real-World Study.
    J Acquir Immune Defic Syndr. 2022;91.
    >> Share

  8. CAMPBELL CK, Ndukwe S, Dube K, Sauceda JA, et al
    Overcoming Challenges of Online Research: Measures to Ensure Enrollment of Eligible Participants.
    J Acquir Immune Defic Syndr. 2022;91:232-236.
    >> Share

  9. PATIL G, Mbewe EG, Kabundula PP, Smith H, et al
    Longitudinal Cognitive Outcomes in Children With HIV in Zambia: 2-Year Outcomes From the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.
    J Acquir Immune Defic Syndr. 2022;91:217-225.
    >> Share

  10. GEANNOPOULOS K, McMahan C, Maldonado RS, Abbott A, et al
    Retinal Thinning in People With Well-Controlled HIV Infection.
    J Acquir Immune Defic Syndr. 2022;91:210-216.
    >> Share

  11. DUMCHEV K, Kiriazova T, Riabokon S, Shost A, et al
    Comparative Clinical Outcomes With Scale-up of Dolutegravir as First-Line Antiretroviral Therapy in Ukraine.
    J Acquir Immune Defic Syndr. 2022;91:197-209.
    >> Share

  12. DORWARD J, Naidoo J, Moodley P, Sookrajh Y, et al
    Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
    J Acquir Immune Defic Syndr. 2022;91:189-196.
    >> Share

  13. CAPPARELLI EV, Ajibola G, Maswabi K, Holme MP, et al
    Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children.
    J Acquir Immune Defic Syndr. 2022;91:182-188.
    >> Share

  14. LAM JO, Leyden WA, Leong TK, Horberg MA, et al
    Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection.
    J Acquir Immune Defic Syndr. 2022;91:175-181.
    >> Share

  15. WOMACK JA, Murphy TE, Leo-Summers L, Bates J, et al
    Predictive Risk Model for Serious Falls Among Older Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2022;91:168-174.
    >> Share

  16. ROSS RD, Olali AZ, Shi Q, Hoover DR, et al
    Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.
    J Acquir Immune Defic Syndr. 2022;91:162-167.
    >> Share

  17. CZARNOGORSKI M, Benn P, McCoig C, Nwafor T, et al
    Brief Report: Impact of COVID-19 on Cabotegravir Plus Rilpivirine Long-Acting Dosing Across 6 Ongoing Global Phase IIb and III Clinical Trials.
    J Acquir Immune Defic Syndr. 2022;91:157-161.
    >> Share

  18. GOEDEL WC, Rogers BG, Li Y, Nunn AS, et al
    Pre-exposure Prophylaxis Discontinuation During the COVID-19 Pandemic Among Men Who Have Sex With Men in a Multisite Clinical Cohort in the United States.
    J Acquir Immune Defic Syndr. 2022;91:151-156.
    >> Share

  19. MORGAN E, Caba AE, Eaton LA, Watson RJ, et al
    PrEP Access Affected by COVID-19 Is Associated With Increased Odds of HIV Seroconversion.
    J Acquir Immune Defic Syndr. 2022;91:138-143.
    >> Share

  20. BEESHAM I, Parikh UM, Mellors JW, Joseph Davey DL, et al
    High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study.
    J Acquir Immune Defic Syndr. 2022;91:130-137.
    >> Share

  21. MCCLYMONT E, Faber MT, Lindquist S, Bone JN, et al
    Human Papillomavirus Infection Among Pregnant Women Living With HIV: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2022;91:122-129.
    >> Share

  22. PATEL D, Williams WO, Wright C, Taylor-Aidoo N, et al
    HIV Testing Services Outcomes in CDC-Funded Health Departments During COVID-19.
    J Acquir Immune Defic Syndr. 2022;91:117-121.
    >> Share

    September 2022
  23. NEVREKAR N, Butler K, Shapiro DE, Atuhaire P, et al
    Self-Reported Antiretroviral Adherence: Association with Maternal Viral Load Suppression in Postpartum Women Living with HIV-1 from Promoting Maternal and Infant Survival Everywhere (PROMISE), a Randomized Controlled Trial in Sub-Saharan Africa and In
    J Acquir Immune Defic Syndr. 2022 Sep 28. pii: 00126334-990000000-00117.
    >> Share

  24. CRANMER LM, Njuguna IN, LaCourse SM, Figueroa J, et al
    Performance of Tuberculosis symptom screening among hospitalized ART-naive Children with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Sep 26. pii: 00126334-990000000-00123.
    >> Share

  25. WANG G, Song W, Rao S, Heitgerd J, et al
    HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-exposure Prophylaxis Awareness and Referral among Men Who Have Sex with Men Tested in Non-healthcare Settings in the United States, 2019.
    J Acquir Immune Defic Syndr. 2022 Sep 26. pii: 00126334-990000000-00125.
    >> Share

  26. VYAS KJ, Marconi VC, Moanna A, Rimland D, et al
    Trends in Cause-Specific Mortality among Veterans with HIV: A 35-Year (1982-2016) Analysis of the HIV Atlanta VA Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Sep 26. pii: 00126334-990000000-00124.
    >> Share

  27. CHAMMARTIN F, Darling K, Abela IA, Battegay M, et al
    CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: The Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00116.
    >> Share

  28. LEMON TL, Tassiopoulos K, Tsai AC, Cantos K, et al
    Health insurance coverage, clinical outcomes, and health-related quality of life among youth born to women living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00120.
    >> Share

  29. PALELLA FJ, Hou Q, Li J, Mahnken J, et al
    Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00121.
    >> Share

  30. MOORE DM, Nanfuka M, Zhang W, Okoboi S, et al
    Limited impact of first-line drug resistance mutations on virologic response among patients receiving second-line anti-retroviral therapy in rural Uganda.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00118.
    >> Share

  31. JACKA BP, Nolen S, Bessey S, Zang X, et al
    Use of pre-exposure prophylaxis (PrEP) to prevent rapid HIV transmission among people who inject drugs (PWID) in rural counties in the United States: A modeling study.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00122.
    >> Share

  32. ADEBAJO SB, Adebiyi R, Chama J, Bello S, et al
    Depression and Sexual Stigma are Associated with Cardiometabolic Risk among Sexual and Gender Minorities Living with HIV in Nigeria.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00119.
    >> Share

  33. BODLEY N, Dorward J, Naidoo J, Letsoalo M, et al
    Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00115.
    >> Share

  34. FAINI D, Msafiri F, Munseri P, Bakari M, et al
    The prevalence, incidence and risk factors for HIV among female sex workers - a cohort being prepared for a phase IIb HIV vaccine trial in Dar es Salaam, Tanzania.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00113.
    >> Share

  35. BOURGI K, Ofner S, Musick B, Griffith B, et al
    Weight Gain among Treatment-naive Persons with HIV Receiving Dolutegravir in Kenya.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00114.
    >> Share

  36. HARRIS RM, Xavier Hall CD, Mills JC, Pence BW, et al
    Beyond viral suppression - The impact of cumulative violence on health-related quality of life among a cohort of virally suppressed patients.
    J Acquir Immune Defic Syndr. 2022 Sep 12. pii: 00126334-990000000-00112.
    >> Share

  37. NYAKATO P, Christ B, Anderegg N, Muhairwe J, et al
    High unreported mortality in children and youth (<25 years) living with HIV who were lost to care from antiretroviral therapy programs in Southern Africa: results from a multi-country tracing study.
    J Acquir Immune Defic Syndr. 2022 Sep 9. pii: 00126334-990000000-00108.
    >> Share

  38. OPSTEEN S, Moylan D, Taiwo BO, Robertson KR, et al
    Intracellular cystatin B levels are altered in HIV-infected participants with respect to neurocognitive status and anti-retroviral therapy.
    J Acquir Immune Defic Syndr. 2022 Sep 9. pii: 00126334-990000000-00107.
    >> Share

  39. XIA Q, Maduro GA, Li W, Huynh M, et al
    Life expectancy among people with HIV in New York City, 2009-2018.
    J Acquir Immune Defic Syndr. 2022 Sep 8. pii: 00126334-990000000-00109.
    >> Share

  40. MORRIS SR, Jain S, Blumenthal J, Bolan R, et al
    Randomized Trial of Individualized Texting for Adherence Building (iTAB) plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study).
    J Acquir Immune Defic Syndr. 2022 Sep 8. pii: 00126334-990000000-00110.
    >> Share

  41. LECHIILE K, Leeme TB, Tenforde MW, Bapabi M, et al
    Laboratory Evaluation of the VISITECT(R) Advanced Disease Semi-quantitative Point-of-care CD4 Test.
    J Acquir Immune Defic Syndr. 2022 Sep 8. pii: 00126334-990000000-00111.
    >> Share

  42. ARENS Y, Bilker WB, Han X, Plankey M, et al
    HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 5. pii: 00126334-990000000-00106.
    >> Share

  43. DRUMMOND MB, Edmonds A, Ramirez C, Stosor V, et al
    Association between HIV and prevalence and manifestations of asthma: Analysis of the Multicenter AIDS Cohort Study and Women's Interagency HIV Study.
    J Acquir Immune Defic Syndr. 2022 Sep 5. pii: 00126334-990000000-00105.
    >> Share

  44. RAMOS MI, Prieto Tato LM, Martin SG, Gomez MLN, et al
    Clinical and epidemiologic characteristics of a cohort of HIV-infected mother-infant pairs during 21 years.
    J Acquir Immune Defic Syndr. 2022 Sep 2. pii: 00126334-990000000-00104.
    >> Share

  45. CAMPBELL DM, Cowlings PD, Tholanah M, Robinson MJ, et al
    "In diversity there is beauty and there is strength." -Dr. Maya Angelou A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-Related Research.
    J Acquir Immune Defic Syndr. 2022 Sep 2. pii: 00126334-990000000-00103.
    >> Share

  46. CHENCINER L, Symonds M, Dissanayake O, Hunter A, et al
    Lymphocyte-CRP Ratio and CRP-Albumin Ratio as Potential Inflammation Markers in Adults With HIV.
    J Acquir Immune Defic Syndr. 2022;91:e1-e3.
    >> Share

  47. SOLANKE T, Kamau F, Esterhuizen T, Maartens G, et al
    Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2022;91:101-108.
    >> Share

  48. MOLINA JM, Yazdanpanah Y, Afani Saud A, Bettacchi C, et al
    Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
    J Acquir Immune Defic Syndr. 2022;91:68-72.
    >> Share

  49. LEWIS MA, Harshbarger C, Bann C, Marconi VC, et al
    Effectiveness of an Interactive, Highly Tailored "Video Doctor" Intervention to Suppress Viral Load and Retain Patients With HIV in Clinical Care: A Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2022;91:58-67.
    >> Share

  50. BEESHAM I, Mansoor LE, Joseph Davey DL, Palanee-Phillips T, et al
    Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial.
    J Acquir Immune Defic Syndr. 2022;91:26-30.
    >> Share

  51. KAMIRE V, Magut F, Khagayi S, Kambona C, et al
    HIV Risk Factors and Risk Perception Among Adolescent Girls and Young Women: Results From a Population-Based Survey in Western Kenya, 2018.
    J Acquir Immune Defic Syndr. 2022;91:17-25.
    >> Share

  52. LLIBRE JM, Lopez Cortes LF, Aylott A, Wynne B, et al
    Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2.
    J Acquir Immune Defic Syndr. 2022;91:73-78.
    >> Share

  53. COUTINHO CM, Warshaw MG, Duarte G, Stek A, et al
    Effects of initiating raltegravir-based versus efavirenz-based antiretroviral regimens during pregnancy on weight changes and perinatal outcomes: NICHD P1081.
    J Acquir Immune Defic Syndr. 2022 Sep 1. pii: 00126334-990000000-00100.
    >> Share

    August 2022
  54. COBURN SB, Lang R, Zhang J, Palella FJ, et al
    Statins utilization in adults with HIV: The treatment gap and predictors of statin initiation.
    J Acquir Immune Defic Syndr. 2022 Aug 31. pii: 00126334-990000000-00102.
    >> Share

  55. MUYINDIKE WR, Fatch R, Cheng DM, Emenyonu NI, et al
    Unhealthy Alcohol Use is Associated with sub-Optimal Adherence to Isoniazid Preventive Therapy in Persons with HIV in southwestern Uganda.
    J Acquir Immune Defic Syndr. 2022 Aug 30. pii: 00126334-990000000-00101.
    >> Share

  56. SINGH P, Moulton LH, Barnes GL, Gupta A, et al
    Pregnancy in Women with HIV in a Tuberculosis Preventive Therapy Trial.
    J Acquir Immune Defic Syndr. 2022 Aug 24. pii: 00126334-990000000-00099.
    >> Share

  57. MATHUR P, Kottilil S, Pallikkuth S, Frasca D, et al
    Persistent CD38 expression on CD8+ T lymphocytes contributes to altered mitochondrial function and chronic inflammation in people with HIV, despite ART.
    J Acquir Immune Defic Syndr. 2022 Aug 24. pii: 00126334-990000000-00098.
    >> Share

  58. CALZA L, Bon I, Pensalfine G, Vitale S, et al
    CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR.
    J Acquir Immune Defic Syndr. 2022 Aug 18. pii: 00126334-990000000-00095.
    >> Share

  59. DRAGONI F, Rossetti B, Lombardi F, Raffaelli CS, et al
    Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00092.
    >> Share

  60. JIAMSAKUL A, Gani Y, Avihingsanon A, Azwa I, et al
    Mortality after loss to follow-up - a linkage study of people living with HIV in Thailand and Malaysia.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00094.
    >> Share

  61. STEINERT JI, Shenderovich Y, Smith M, Zhou S, et al
    Economic wellbeing and associated mediating pathways to improved antiretroviral therapy adherence among adolescents living with HIV: A prospective cohort study in South Africa.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00091.
    >> Share

  62. ANDERSON AM, Bhondoekhan F, Curanovic D, Connelly MA, et al
    Higher soluble CD163 in blood is associated with significant depression symptoms in men with HIV.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00093.
    >> Share

  63. TSENG AS, Sambai B, Monroe-Wise A, Mbogo LW, et al
    Assisted partner services for people who inject drugs: Index characteristics associated with untreated HIV in partners.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00089.
    >> Share

  64. GROENENDIJK AL, Vos WAJW, Dos Santos JC, Rokx C, et al
    Non-AIDS-events in individuals with spontaneous control of HIV-1: a systematic review.
    J Acquir Immune Defic Syndr. 2022 Aug 15. pii: 00126334-990000000-00090.
    >> Share

  65. YOON H, Hemmige VS, Lee A, Conway-Pearson LS, et al
    Cryptococcal antigen screening and missed opportunities for earlier diagnosis among people with HIV and poor virologic control in the Bronx, N.Y.
    J Acquir Immune Defic Syndr. 2022 Aug 11. pii: 00126334-990000000-00087.
    >> Share

  66. WEISS F, von Both U, Rack-Hoch A, Sollinger F, et al
    HIV-Positive and Breastfeeding in High-Income Settings: 5-year Experience from a Perinatal Center in Germany.
    J Acquir Immune Defic Syndr. 2022 Aug 9. pii: 00126334-990000000-00088.
    >> Share

  67. ESBER A, Dear N, Shah N, Kibuuka H, et al
    Virologic impact of the dolutegravir transition: prospective results from the multinational African Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Aug 3. pii: 00126334-990000000-00084.
    >> Share

    July 2022
  68. VAUGHAN J, Perner Y, Wiggill T
    Diffuse Large B-cell Lymphoma in the public-sector of Johannesburg, South Africa, in the era of widescale Anti-retroviral therapy use.
    J Acquir Immune Defic Syndr. 2022 Jul 29. pii: 00126334-990000000-00082.
    >> Share

  69. GUPTA R, Hussain S, Hariprasad R, Dhanasekaran K, et al
    Concurrent cervical and anal high-risk human papillomavirus infection in women living with HIV: an observational case-control study.
    J Acquir Immune Defic Syndr. 2022 Jul 29. pii: 00126334-990000000-00083.
    >> Share

  70. TIEOSAPJAROEN W, Fairley CK, Eric CPF, Ivette A, et al
    Preferences for weight gain compared with other antiretroviral therapy side effects in people living with HIV: a discrete choice experiment.
    J Acquir Immune Defic Syndr. 2022 Jul 21. pii: 00126334-990000000-00079.
    >> Share

  71. WENDT CH, Samorodnitsky S, Lock EF, Kruk M, et al
    The lung and plasma metabolome in HIV-associated obstructive lung disease (OLD).
    J Acquir Immune Defic Syndr. 2022 Jul 15. pii: 00126334-990000000-00080.
    >> Share

  72. BROWN LK, Baltrusaitis K, Kennard BD, Emslie GJ, et al
    Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth with HIV in the United States.
    J Acquir Immune Defic Syndr. 2022 Jul 15. pii: 00126334-990000000-00081.
    >> Share

  73. BRUZZESI E, Galli L, Poli A, Bossolasco S, et al
    PREVALENCE AND RISK FACTORS OF ANAL HPV INFECTION IN MSM LIVING WITH HIV: IDENTIFYING THE TARGET GROUPS TO PRIORITIZE FOR IMMUNIZATION.
    J Acquir Immune Defic Syndr. 2022 Jul 11. pii: 00126334-900000000-95605.
    >> Share

  74. LI DH, Benbow N, Keiser B, Mongrella M, et al
    Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  75. JONES J, Knox J, Meanley S, Yang C, et al
    Explorations of the Role of Digital Technology in HIV-Related Implementation Research: Case Comparisons of Five Ending the HIV Epidemic Supplement Awards.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  76. RODRIGUEZ-HART C, Mackson G, Belanger D, West N, et al
    Reducing Intersecting Stigmas in HIV Service Organizations: An Implementation Science Model.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  77. GARNER BR, Knudsen HK, Zulkiewicz BA, Tueller SJ, et al
    The Setting-Intervention Fit of Nine Evidence-Based Interventions for Substance Use Disorders Within HIV Service Organizations Across the United States: Results of a National Stakeholder-Engaged Real-Time Delphi Study.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  78. STUMP TK, Ethier K, Hirschhorn LR, Dakin A, et al
    Development of an Implementation Facilitation Strategy to Link Mental Health Screening and eHealth Intervention for Clients in Ryan White-Funded Clinics in Chicago.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  79. SANCHEZ AL, Hoskins K, Pettit AR, Momplaisir F, et al
    Stakeholder Perspectives on MAPS.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  80. HARKNESS A, Wawrzyniak AJ, Kolber MA, Villamizar K, et al
    Multilevel Determinants of Rapid Antiretroviral Treatment Implementation and Demand in Miami-Dade County.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  81. DRABO EF, Moucheraud C, Nguyen A, Garland WH, et al
    Using Microsimulation Modeling to Inform EHE Implementation Strategies in Los Angeles County.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  82. CREGER T, Burgan K, Turner WH, Tarrant A, et al
    Using Implementation Mapping to Ensure the Success of PrEP Optimization Through Enhanced Continuum Tracking (PrOTECT) AL-A Structural Intervention to Track the Statewide PrEP Care Continuum in Alabama.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  83. CORNELI A, Perry B, Wilson J, Reif S, et al
    Identification of Determinants and Implementation Strategies to Increase PrEP Uptake Among Black Same Gender-Loving Men in Mecklenburg County, North Carolina: The PrEP-MECK Study.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  84. JOHNSON AK, Pyra M, Devlin S, Uvin AZ, et al
    Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  85. USKUP DK, Nieto O, Rosenberg-Carlson E, Lee SJ, et al
    Acceptability and Appropriateness of Digital PrEP Interventions for Black and Latina Cisgender Women: Perspectives From Service Providers in Los Angeles County.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  86. SONALKAR S, McAllister A, Kete C, Fishman J, et al
    Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  87. FARO EZ, Mantell JE, Gonzalez-Argoti T, Hoffman S, et al
    Implementing PrEP Services in Diverse Health Care Settings.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  88. KING K, Balan S, Kanamori M, Shrader CH, et al
    Feasibility and Acceptability of HIV Self-Test Kit Distribution Through PrEP Clients' Social and Sexual Networks to Increase HIV Testing and PrEP Information.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  89. TSUYUKI K, Stockman JK, Stadnick NA, Moore V, et al
    Proyecto Compadre: Using Implementation Science to Tailor Peer Navigation for Latino Men in the US-Mexico Border Region.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  90. WOOD SM, Meanley S, Bonett S, Torres ME, et al
    Strengthening HIV Prevention Services Through an Implementation Science Approach: Perspectives From the HIV Testers in Philadelphia.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  91. FIELDS EL, Thornton N, Huettner S, Schumacher C, et al
    Safe Spaces 4 Sexual Health: A Status-Neutral, Mobile Van, HIV/STI Testing Intervention Using Online Outreach to Reach MSM at High Risk for HIV Acquisition or Transmission.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  92. NAAR S, MacDonell K, Chapman J, Todd L, et al
    Tailored Motivational Interviewing in Adolescent HIV Clinics: Primary Outcome Analysis of a Stepped Wedge Implementation Trial.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  93. RAJABIUN S, Killion K, Lennon-Dearing R, Williams BB, et al
    Using Implementation Science to Promote Integration and Sustainability of Community Health Workers in the HIV Workforce.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  94. PETTIT AC, Pichon LC, Ahonkhai AA, Robinson C, et al
    Comprehensive Process Mapping and Qualitative Interviews to Inform Implementation of Rapid Linkage to HIV Care Programs in a Mid-Sized Urban Setting in the Southern United States.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  95. HARRISON SE, Muessig K, Poteat T, Koester K, et al
    Addressing Racism's Role in the US HIV Epidemic: Qualitative Findings From Three Ending the HIV Epidemic Prevention Projects.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  96. BERES LK, Schwartz S, Mody A, Geng EH, et al
    Five Common Myths Limiting Engagement in HIV-Related Implementation Research.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  97. SCHWARTZ SR, Chavez Ortiz J, Smith JD, Beres LK, et al
    Data Velocity in HIV-Related Implementation Research: Estimating Time From Funding to Publication.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  98. QUEIROZ A, Mongrella M, Keiser B, Li DH, et al
    Profile of the Portfolio of NIH-Funded HIV Implementation Research Projects to Inform Ending the HIV Epidemic Strategies.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  99. PURCELL DW, Namkung Lee A, Dempsey A, Gordon C, et al
    Enhanced Federal Collaborations in Implementation Science and Research of HIV Prevention and Treatment.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  100. GLENSHAW MT, Gaist P, Wilson A, Cregg RC, et al
    Role of NIH in the Ending the HIV Epidemic in the US Initiative: Research Improving Practice.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  101. MUSTANSKI B, Smith JD, Keiser B, Li DH, et al
    Supporting the Growth of Domestic HIV Implementation Research in the United States Through Coordination, Consultation, and Collaboration: How We Got Here and Where We Are Headed.
    J Acquir Immune Defic Syndr. 2022;90.
    >> Share

  102. ODAYAR J, Chi BH, Phillips TK, Mukonda E, et al
    Transfer of Patients on Antiretroviral Therapy Attending Primary Health Care Services in South Africa.
    J Acquir Immune Defic Syndr. 2022;90:309-315.
    >> Share

    June 2022
  103. ARORA AK, Lessard D, Dube K, Lebouche B, et al
    It's Time to Embed Health-related Quality of Life across all Steps of the HIV Care Cascade.
    J Acquir Immune Defic Syndr. 2022 Jun 30. pii: 00126334-990000000-00071.
    >> Share

    May 2022
  104. BALASUBRAMANIAN R, Kasaie P, Schnure M, Dowdy DW, et al
    PROJECTED IMPACT OF EXPANDED LONG-ACTING INJECTABLE PREP USE AMONG MEN WHO HAVE SEX WITH MEN ON LOCAL HIV EPIDEMICS.
    J Acquir Immune Defic Syndr. 2022 May 30. pii: 00126334-990000000-00055.
    >> Share

  105. KIWEEWA FM, Tierney C, Butler K, Peters MG, et al
    Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women with HIV/ HBV Co-infection.
    J Acquir Immune Defic Syndr. 2022 May 27. pii: 00126334-990000000-00050.
    >> Share

  106. EL-NAHAL WG, Shen NM, Keruly JC, Jones JL, et al
    Time Between Viral Loads for People with HIV during the COVID-19 Pandemic.
    J Acquir Immune Defic Syndr. 2022 May 26. pii: 00126334-990000000-00051.
    >> Share

  107. KHERABI Y, de Castro N, Sellier PO, Hamet G, et al
    Efficacy and safety of efavirenz, raltegravir and dolutegravir in HIV-1/TB co-infection. A multicenter retrospective cohort study in France.
    J Acquir Immune Defic Syndr. 2022 May 26. pii: 00126334-990000000-00052.
    >> Share

  108. JONES DL, Zhang Y, Rodriguez VJ, Haberlen S, et al
    Association of PTSD with Longitudinal COVID-19 Burden in a Mixed-Serostatus Cohort of Men and Women: Weathering the Storm.
    J Acquir Immune Defic Syndr. 2022 May 19. pii: 00126334-990000000-00048.
    >> Share

  109. JAWA R, Walley AY, Wilson DJ, Green TC, et al
    Prescribe to Save Lives: Improving buprenorphine prescribing among HIV clinicians.
    J Acquir Immune Defic Syndr. 2022 May 18. pii: 00126334-990000000-00047.
    >> Share

  110. GARNER BR, Burrus O, Ortiz A, Tueller SJ, et al
    A longitudinal mixed-methods examination of Positive Health Check: Implementation results from a type 1 effectiveness-implementation hybrid trial.
    J Acquir Immune Defic Syndr. 2022 May 18. pii: 00126334-990000000-00044.
    >> Share

  111. HILL BJ, Motley DN, Rosentel K, VandeVusse A, et al
    Employment as HIV prevention: An employment support intervention for adolescent men who have sex with men and adolescent transgender women of color.
    J Acquir Immune Defic Syndr. 2022 May 12. pii: 00126334-990000000-00045.
    >> Share

  112. NDENKEH JN, Bowring AL, Njindam IM, Folem RD, et al
    HIV pre-exposure prophylaxis uptake and continuation among key populations in Cameroon: Lessons learned from the CHAMP program.
    J Acquir Immune Defic Syndr. 2022 May 10. pii: 00126334-990000000-00043.
    >> Share

  113. USSERY F, Bachanas P, Alwano MG, Lebelonyane R, et al
    HIV incidence in Botswana rural communities with high antiretroviral treatment coverage: Results from the Botswana Combination Prevention Project, 2013-2017.
    J Acquir Immune Defic Syndr. 2022 May 6. pii: 00126334-990000000-00042.
    >> Share

  114. HAMILTON DT, Agutu C, Babigumira JB, van der Elst E, et al
    Modeling the Impact of HIV-1 Nucleic Acid Testing among Symptomatic Adult Outpatients in Kenya.
    J Acquir Immune Defic Syndr. 2022 May 4. pii: 00126334-990000000-00040.
    >> Share

  115. ROY CARDINAL MH, Durand M, Chartrand-Lefebvre C, Soulez G, et al
    Associative prediction of carotid artery plaques based on ultrasound strain imaging and cardiovascular risk factors in people living with HIV and age-matched control subjects of the CHACS cohort.
    J Acquir Immune Defic Syndr. 2022 May 4. pii: 00126334-990000000-00041.
    >> Share

  116. SEVELIUS JM, Dilworth SE, Reback CJ, Chakravarty D, et al
    Randomized Controlled Trial of Healthy Divas: A Gender-Affirming, Peer-Delivered Intervention to Improve HIV Care Engagement among Transgender Women Living with HIV.
    J Acquir Immune Defic Syndr. 2022 May 3. pii: 00126334-990000000-00039.
    >> Share

  117. HECHTER RC, Bruxvoort KJ, Zhou H, Towner WJ, et al
    Sexually transmitted infections among men and transgender women using HIV pre-exposure prophylaxis in a large integrated health system- a cohort study.
    J Acquir Immune Defic Syndr. 2022 May 2. pii: 00126334-990000000-00038.
    >> Share

  118. MCMAHON DE, Chemtai L, Grant M, Singh R, et al
    Understanding Diagnostic Delays for Kaposi Sarcoma in Kenya: A Qualitative Study.
    J Acquir Immune Defic Syndr. 2022 May 2. pii: 00126334-990000000-00037.
    >> Share

  119. KOBAYASHI M, Matanock A, Xing W, Adih WK, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV-United States, 2008-2018.
    J Acquir Immune Defic Syndr. 2022;90:6-14.
    >> Share

    April 2022
  120. CANNON CA, Ramchandani MS, Buskin S, Dombrowski J, et al
    Previous Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men Newly Diagnosed with HIV Infection in King County, Washington.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00035.
    >> Share

  121. WOOD BR, Bauer K, Lechtenberg R, Buskin SE, et al
    Direct and indirect effects of a Project ECHO longitudinal clinical tele-mentoring program on viral suppression for persons with HIV: a population-based analysis.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00033.
    >> Share

  122. CLOSSON K, Lee M, Gibbs A, Nicholson V, et al
    Sexual relationship power equity is associated with consistent condom use and fewer experiences of recent violence among women living with HIV in Canada.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00036.
    >> Share

  123. NEARY J, Bulterys MA, Ogutu EA, O'Malley G, et al
    Pediatric saliva-based HIV testing: healthcare worker and caregiver acceptability.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00032.
    >> Share

  124. RAMCHANDANI MS, Berzkalns A, Cannon CA, Dombrowski JC, et al
    A De-medicalized Model to Provide PrEP in a Sexual Health Clinic.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00034.
    >> Share

  125. KWAPONG YA, Sharma G, Shade JK, Piggott DA, et al
    Effect of HIV Serostatus on ICU Admission and Mortality among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients.
    J Acquir Immune Defic Syndr. 2022 Apr 28. pii: 00126334-990000000-00031.
    >> Share

  126. ZEWDIE K, Kiptinness C, Ngure K, Kipkurui N, et al
    Targeted implementation of HIV self-testing increases testing uptake among partners of index persons known to have HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Apr 27. pii: 00126334-990000000-00030.
    >> Share

  127. JOHNSTON CD, Siegler EL, Rice MC, Derry-Vick HM, et al
    Plasma Cell-Free Mitochondrial DNA as a Marker of Geriatric Syndromes in Older Adults with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 26. pii: 00126334-990000000-00029.
    >> Share

  128. SCHROTER J, Anelone AJN, de Boer RJ
    Quantification of CD4 Recovery in Early-Treated Infants Living With HIV.
    J Acquir Immune Defic Syndr. 2022;89:546-557.
    >> Share

  129. RESCH SC, Foote JHA, Wirth KE, Lasry A, et al
    Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project.
    J Acquir Immune Defic Syndr. 2022 Apr 14. pii: 00126334-990000000-00021.
    >> Share

  130. MONTGOMERY ET, Roberts ST, Reddy K, Tolley EE, et al
    The CHARISMA randomized controlled trial: a relationship-focused counseling intervention integrated within oral PrEP delivery for HIV prevention among women in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2022 Apr 13. pii: 00126334-990000000-00025.
    >> Share

  131. OVERTON ET, Weir IR, Zanni MV, Fischinger S, et al
    Asymptomatic SARS-CoV-2 Infection is Common among ART-treated People with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 12. pii: 00126334-990000000-00027.
    >> Share

  132. OLIVIERI-MUI B, Shi S, McCarthy EP, Montano M, et al
    Categorizing comorbid risk for people living with HIV: a latent profile analysis.
    J Acquir Immune Defic Syndr. 2022 Apr 12. pii: 00126334-990000000-00028.
    >> Share

  133. ANDERSON MA, Chimbetete C, Shamu T, Dahwa R, et al
    "Validation of the D:A:D Chronic Kidney Disease Risk Score Incorporating Proteinuria in People Living with HIV in Harare, Zimbabwe".
    J Acquir Immune Defic Syndr. 2022 Apr 12. pii: 00126334-990000000-00026.
    >> Share

  134. LUO G, Su L, Hu Y, Zhou Y, et al
    The impact of COVID-19 restrictions on online sales of HIV self-test kits and implications for HIV prevention: analysis of transaction data from a leading e-commerce platform in China.
    J Acquir Immune Defic Syndr. 2022 Apr 8. pii: 00126334-990000000-00023.
    >> Share

  135. LARSEN AM, Osborn L, Ronen K, Richardson BA, et al
    Trajectories of depression symptoms from pregnancy through 24 months postpartum among Kenyan women living with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 8. pii: 00126334-990000000-00024.
    >> Share

  136. KHALIFA A, Findley S, Gummerson E, Mantell JE, et al
    Associations between mobility, food insecurity and transactional sex among women in cohabitating partnerships: an analysis from six African countries 2016-2017.
    J Acquir Immune Defic Syndr. 2022 Apr 6. pii: 00126334-990000000-00022.
    >> Share

  137. SIM MMS, Banerjee M, Myint T, Garvy BA, et al
    Total Plasma Protein S is a prothrombotic marker in People Living with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 4. pii: 00126334-990000000-00020.
    >> Share

  138. SALONER R, Savini N, Letendre SL, Moore DJ, et al
    Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022;89:454-461.
    >> Share

  139. LATHAM AH, Nissim OA, Spitznagel MC, Kirk SE, et al
    Impact of Integrase Strand Transfer Inhibitor Use During Pregnancy on Viral Suppression at Delivery and Infant Outcomes: A Statewide Retrospective Cohort Study.
    J Acquir Immune Defic Syndr. 2022;89:448-453.
    >> Share

  140. BENKI-NUGENT SF, Yunusa R, Mueni A, Laboso T, et al
    Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children.
    J Acquir Immune Defic Syndr. 2022;89:441-447.
    >> Share

  141. REMERA E, Nsanzimana S, Chammartin F, Semakula M, et al
    Brief Report: Active HIV Case Finding in the City of Kigali, Rwanda: Assessment of Voluntary Assisted Partner Notification Modalities to Detect Undiagnosed HIV Infections.
    J Acquir Immune Defic Syndr. 2022;89:423-427.
    >> Share

  142. KIM HN, Nance RM, Lo Re V 3rd, Silverberg MJ, et al
    Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV.
    J Acquir Immune Defic Syndr. 2022;89:396-404.
    >> Share

  143. MORRIS S, Cottrell M, Rawlings SA, Peterson S, et al
    Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP.
    J Acquir Immune Defic Syndr. 2022;89:390-395.
    >> Share

  144. JACOBSON EU, Hicks KA, Carrico J, Purcell DW, et al
    Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.
    J Acquir Immune Defic Syndr. 2022;89:374-380.
    >> Share

  145. SHANGASE N, Edwards J, Pence B, Aiello A, et al
    Effect of Quality of Caregiver-Adolescent Relationship on Sexual Debut, Transactional Sex, and on Age-Disparate Relationships Among Young Women in Rural South Africa Enrolled in HPTN 068.
    J Acquir Immune Defic Syndr. 2022;89:366-373.
    >> Share

  146. CHAN CT, Ming K, Camp C, Saberi P, et al
    Sexual Behaviors, Substance Use, and Quality of Life Among Individuals Using PrEP in San Francisco During the COVID-19 Pandemic Shelter-In-Place Orders: A Cross-Sectional Survey.
    J Acquir Immune Defic Syndr. 2022;89:e39-e42.
    >> Share

  147. SALONER R, Lobo JD, Paolillo EW, Campbell LM, et al
    Cognitive and Physiologic Reserve Independently Relate to Superior Neurocognitive Abilities in Adults Aging with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00016.
    >> Share

  148. SHAPIRO AE, Bender Ignacio RA, Whitney BM, Delaney JA, et al
    Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00019.
    >> Share

  149. BACHA JM, Dlamini S, Anabwani F, Gwimile J, et al
    Achieving antiretroviral therapy uptake and viral suppression among children and adolescents living with HIV in the UNAIDS 90-90-90 era across six countries in Eastern and Southern Africa - lessons from the BIPAI Network.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00018.
    >> Share

  150. SHARPLESS L, Kershaw T, Hatcher A, Alexander KA, et al
    Intimate Partner Violence (IPV) and Patient-Provider Communication about HIV Pre-Exposure Prophylaxis (PrEP): The Moderating Role of IPV-Specific Medical Mistrust.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00017.
    >> Share

    March 2022
  151. PATHELA P, Qasmieh S, Gandhi M, Rozen E, et al
    Use of remnant specimens to assess use of HIV pre-exposure prophylaxis (PrEP) among populations with risk for HIV infection: A novel approach.
    J Acquir Immune Defic Syndr. 2022 Mar 31. pii: 00126334-990000000-00015.
    >> Share

  152. BROWNE EN, Brown ER, Palanee-Phillips T, Reddy K, et al
    Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2022 Mar 28. pii: 00126334-990000000-00014.
    >> Share

  153. PSOMAS CK, Hoover DR, Shi Q, Brown TT, et al
    POLYPHARMACY IS ASSOCIATED WITH FALLS IN WOMEN WITH AND WITHOUT HIV.
    J Acquir Immune Defic Syndr. 2022 Mar 25. pii: 00126334-990000000-00013.
    >> Share

  154. WACHIRA J, Genberg B, Mwangi A, Chemutai D, et al
    Impact of an enhanced patient care (EPC) intervention on viral suppression among patients living with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Mar 23. pii: 00126334-990000000-00012.
    >> Share

  155. MENG W, Chen M, Song Y, Zhang H, et al
    Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: a Chinese Cross-sectional Study.
    J Acquir Immune Defic Syndr. 2022 Mar 22. pii: 00126334-990000000-00011.
    >> Share

  156. GOEDEL WC, Coats CS, Chan PA, Sims-Gomillia CE, et al
    A Pilot Study of a Patient Navigation Intervention to Improve HIV Pre-Exposure Prophylaxis Persistence Among Black/African American Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2022 Mar 21. pii: 00126334-990000000-00010.
    >> Share

  157. GEORGE G, Beckett S, Reddy T, Govender K, et al
    The role of schooling and comprehensive sexuality education in reducing HIV and pregnancy among adolescents in South Africa.
    J Acquir Immune Defic Syndr. 2022 Mar 18. pii: 00126334-990000000-00009.
    >> Share

  158. TAN Y, Zou S, Ming F, Zhang Z, et al
    Early efficacy and safety of the third dose inactivated COVID-19 vaccine among people living with HIV.
    J Acquir Immune Defic Syndr. 2022 Mar 17. pii: 00126334-990000000-00006.
    >> Share

  159. KUSEJKO K, Tschumi N, Chaudron SE, Nguyen H, et al
    Similar but different: Integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics.
    J Acquir Immune Defic Syndr. 2022 Mar 17. pii: 00126334-990000000-00007.
    >> Share

  160. UNGER ZD, Golub SA, Borges C, Edelstein ZR, et al
    Reasons for PrEP Discontinuation Following Navigation at Sexual Health Clinics: Interactions among Systemic Barriers, Behavioral Relevance, and Medication Concerns.
    J Acquir Immune Defic Syndr. 2022 Mar 14. pii: 00126334-990000000-00005.
    >> Share

  161. IMBERT E, Hickey MD, Del Rosario JB, Conte M, et al
    Heterogeneous preferences for care engagement among people with HIV experiencing homelessness or unstable housing during the COVID-19 pandemic.
    J Acquir Immune Defic Syndr. 2022 Mar 9. pii: 00126334-990000000-00002.
    >> Share

  162. STOCKMAN J, Friedman J, Sundberg J, Harris E, et al
    Predictive analytics using machine learning to identify ART clients at health system level at greatest risk of treatment interruption in Mozambique and Nigeria.
    J Acquir Immune Defic Syndr. 2022 Mar 9. pii: 00126334-990000000-00001.
    >> Share

  163. RICE B, Machingura F, Maringwa G, Magutshwa S, et al
    Adolescent girls who sell sex in Zimbabwe: HIV risk, behaviours and service engagement.
    J Acquir Immune Defic Syndr. 2022 Mar 8. pii: 00126334-990000000-00003.
    >> Share

  164. SSEMPIJJA V, Nakigozi G, Ssekubugu R, Kagaayi J, et al
    HIGH RATE OF PRE-EXPOSURE PROPHYLAXIS (PrEP) ELIGIBILITY AND ASSOCIATED HIV INCIDENCE IN A POPULATION WITH A GENERALIZED HIV EPIDEMIC IN RAKAI, UGANDA.
    J Acquir Immune Defic Syndr. 2022 Mar 8. pii: 00126334-990000000-00004.
    >> Share

  165. PELUSO MJ, Williams MC, Campbell DM, Dee L, et al
    SARS-CoV-2 Booster Vaccination for Participants in "HIV Cure"-Related Clinical Trials.
    J Acquir Immune Defic Syndr. 2022;89:e30.
    >> Share

  166. BLOOMFIELD GS, Weir IR, Ribaudo HJ, Fitch KV, et al
    Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
    J Acquir Immune Defic Syndr. 2022;89:349-359.
    >> Share

  167. WHITE DAE, Anderson ES, Basham K, Ng VL, et al
    Clinical Utility of the Signal-to-Cutoff Ratio of Reactive HIV Antigen/Antibody Screening Tests in Guiding Emergency Physician Management.
    J Acquir Immune Defic Syndr. 2022;89:332-339.
    >> Share

  168. FABIAN KE, Muanido A, Cumbe VFJ, Mukunta C, et al
    Integrating a Transdiagnostic Psychological Intervention Into Routine HIV Care: A Mixed-Methods Evaluation of the Common Elements Treatment Approach in Mozambique.
    J Acquir Immune Defic Syndr. 2022;89:274-281.
    >> Share

  169. HABERER JE, Mugo N, Bukusi EA, Ngure K, et al
    Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.
    J Acquir Immune Defic Syndr. 2022;89:251-260.
    >> Share

    February 2022
  170. CLAY CE, Ling A, Bennett CL
    HIV Testing at Visits to United States Emergency Departments, 2018.
    J Acquir Immune Defic Syndr. 2022 Feb 28. pii: 00126334-900000000-95683.
    >> Share

  171. SAMBA BO, Lewis-Kulzer J, Odhiambo F, Juma E, et al
    Exploring Estimates and Reasons for Lost to Follow Up among People Living with HIV on Antiretroviral Therapy in Kisumu County, Kenya.
    J Acquir Immune Defic Syndr. 2022 Feb 24. pii: 00126334-900000000-95684.
    >> Share

  172. PARK LS, McGinnis KA, Gordon KS, Justice AC, et al
    SARS-CoV-2 testing and positivity among persons with and without HIV in 6 United States cohorts.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95688.
    >> Share

  173. BROOKS KM, Pinilla M, Stek AM, Shapiro DE, et al
    Pharmacokinetics of tenofovir alafenamide with boosted protease inhibitors in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95687.
    >> Share

  174. O'DONNELL MR, Padayatchi N, Wolf A, Zelnick J, et al
    Bedaquiline adherence measured by electronic dose monitoring predicts clinical outcomes in the treatment of patients with multidrug-resistant tuberculosis and HIV/AIDS.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95686.
    >> Share

  175. NAKISIGE C, Adams SV, Namirembe C, Okoche L, et al
    Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living with HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95685.
    >> Share

  176. POURCHER V, Capeau J, Dudoit Y, Boccara F, et al
    Comparison of HIV-infected and non-infected patients undergoing bariatric surgery: the ObeVIH study.
    J Acquir Immune Defic Syndr. 2022 Feb 17. pii: 00126334-900000000-95689.
    >> Share

  177. SHUTER J, Chander G, Graham AL, Kim RS, et al
    A randomized trial of a web-based tobacco treatment and online community support for people with HIV attempting to quit smoking cigarettes.
    J Acquir Immune Defic Syndr. 2022 Feb 14. pii: 00126334-900000000-95691.
    >> Share

  178. ZHAO Y, Hohlfeld A, Namale P, Meintjes G, et al
    Risk of immune reconstitution inflammatory syndrome with integrase inhibitors versus other classes of antiretrovirals: a systematic review and meta-analysis of randomised trials.
    J Acquir Immune Defic Syndr. 2022 Feb 14. pii: 00126334-900000000-95690.
    >> Share

  179. CHAN C, Vaccher S, Fraser D, Grulich A, et al
    Incorrect knowledge of event-driven PrEP '2-1-1' dosing regimen among PrEP-experienced gay and bisexual men in Australia.
    J Acquir Immune Defic Syndr. 2022 Feb 7. pii: 00126334-900000000-95694.
    >> Share

  180. NIJHAWAN AE, Zhang S, Chansard M, Gao A, et al
    A Multicomponent Intervention to Reduce Readmissions Among People with HIV.
    J Acquir Immune Defic Syndr. 2022 Feb 7. pii: 00126334-900000000-95693.
    >> Share

  181. LI LJ, Tan P, Hee O, Agrawal R, et al
    Retinal Microvasculature And Immune Restoration Among South Eastern Asian HIV/AIDS Patients Over A 9-Month Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022 Feb 7. pii: 00126334-900000000-95692.
    >> Share

  182. GOERLICH E, Schar M, Bagchi S, Soleimani-Fard A, et al
    Coronary endothelial dysfunction in people living with HIV is related to body fat distribution.
    J Acquir Immune Defic Syndr. 2022 Feb 4. pii: 00126334-900000000-95695.
    >> Share

  183. BOETTIGER DC, An VT, Kumarasamy N, Azwa I, et al
    Recent trends in adult and pediatric antiretroviral therapy monitoring and failure.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95701.
    >> Share

  184. BAILIN SS, Gabriel CL, Fan R, Ye F, et al
    Relationship of Subcutaneous Adipose Tissue Inflammation-related Gene Expression with Ectopic Lipid Deposition in Persons with HIV.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95700.
    >> Share

  185. SPOONER R, Ranasinghe S, Urasa S, Yoseph M, et al
    HIV-Associated Neurocognitive Disorders (HAND): The first longitudinal follow up of a cART-treated cohort of older people in sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95699.
    >> Share

  186. HOFFMAN S, Zhang A, Nguyen N, Tsong R, et al
    Incident HIV Infection among Young Men Associated with Female Sexual Partner Types Identified Through Latent Class Analysis (LCA), Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95698.
    >> Share

  187. JOHNSON LF, Meyer-Rath G, Dorrington RE, Puren A, et al
    The effect of HIV programmes in South Africa on national HIV incidence trends, 2000-2019.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95697.
    >> Share

  188. SELLERS SA, Edmonds A, Ramirez C, Cribbs SK, et al
    Optimal lung cancer screening criteria among persons living with HIV.
    J Acquir Immune Defic Syndr. 2022 Feb 3. pii: 00126334-900000000-95696.
    >> Share

  189. KALICHMAN SC, Eaton LA, Kalichman MO
    Believing that it is Hazardous to Mix Alcohol with Medicines Predicts Intentional Non-Adherence to Antiretrovirals.
    J Acquir Immune Defic Syndr. 2022 Feb 2. pii: 00126334-900000000-95702.
    >> Share

  190. GUARALDI G, Milic J, Barbieri S, Marchio T, et al
    Resilience and Frailty in People Living With HIV During the COVID Era: Two Complementary Constructs Associated With Health-Related Quality of Life.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  191. GHARE S, Singhal R, Bryant V, Gautam S, et al
    Age-Associated Gut Dysbiosis, Marked by Loss of Butyrogenic Potential, Correlates With Altered Plasma Tryptophan Metabolites in Older People Living With HIV.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  192. RINALDI S, Pallikkuth S, De Armas L, Richardson B, et al
    Distinct Molecular Signatures of Aging in Healthy and HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  193. MASTERS MC, Landay AL, Robbins PD, Tchkonia T, et al
    Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  194. ROUTY JP, Royston L, Isnard S
    Aging With Grace for People Living With HIV: Strategies to Overcome Leaky Gut and Cytomegalovirus Coinfection.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  195. FRASCA D, Pallikkuth S, Pahwa S
    Effects of Aging on Metabolic Characteristics of Human B Cells.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  196. TRAN T, Pencina KM, Schultz MB, Li Z, et al
    Reduced Levels of NAD in Skeletal Muscle and Increased Physiologic Frailty Are Associated With Viral Coinfection in Asymptomatic Middle-Aged Adults.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  197. CRANE HM, Drumright L
    HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  198. MONTANO M, Landay A, Perkins M, Holstad M, et al
    HIV and Aging in the Era of ART and COVID-19: Symposium Overview.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

  199. PALLIKKUTH S, Pahwa S
    HIV and Aging in the Era of ART and COVID-19.
    J Acquir Immune Defic Syndr. 2022;89.
    >> Share

    January 2022
  200. DE ALMEIDA SM, Rotta I, Tang B, Umlauf A, et al
    Higher cerebrospinal fluid soluble urokinase-type plasminogen activator receptor, but not interferon gamma-inducible protein 10, correlate with higher working memory deficits.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95706.
    >> Share

  201. EL BOUZIDI K, Murtala-Ibrahim F, Kwaghe V, Datir RP, et al
    Disengagement from HIV care and failure of second-line therapy in Nigeria: a retrospective cohort study, 2005-2017.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95705.
    >> Share

  202. SUAREZ-GARCIA I, Ruiz-Alguero M, Alejos B, Garcia-Yubero C, et al
    Patients' experiences and opinions after de-simplification of their single-tablet regimens for the treatment of HIV infection: a survey in a multicentre cohort.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95704.
    >> Share

  203. WHEATLEY MM, Knowlton G, Kao SY, Jenness SM, et al
    Cost-Effectiveness of Interventions to Improve HIV Pre-Exposure Prophylaxis Initiation, Adherence, and Persistence among Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2022 Jan 26. pii: 00126334-900000000-95703.
    >> Share

  204. WEI-MING WATSON C, Kamalyan L, Tang B, Hussain MA, et al
    Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 25. pii: 00126334-900000000-95707.
    >> Share

  205. GLANS M, Cooley SA, Vaida F, Boerwinkle A, et al
    Effects of Framingham 10-year cardiovascular risk score and viral load on brain integrity in persons with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 21. pii: 00126334-900000000-95709.
    >> Share

  206. LONG JE, Sanchez H, Dasgupta S, Huerta L, et al
    Self-reported knowledge of HIV status among cisgender male sex partners of transgender women in Lima, Peru.
    J Acquir Immune Defic Syndr. 2022 Jan 18. pii: 00126334-900000000-95711.
    >> Share

  207. YOUNG SD, Cumberland WG, Singh P, Coates T, et al
    A Peer-Led Online Community to Increase HIV Self-Testing among African American and Latinx MSM: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2022 Jan 18. pii: 00126334-900000000-95710.
    >> Share

  208. CHEN JS, Pettifor AE, Nelson JA, Phiri S, et al
    Blood and genital fluid viral load trajectories among treated and untreated persons with acute HIV infection in Malawi.
    J Acquir Immune Defic Syndr. 2022 Jan 17. pii: 00126334-900000000-95712.
    >> Share

  209. MOORE DM, Kremer H, Wang L, Lepik KJ, et al
    Evaluation of a public health referral system to re-engage individuals living with HIV who have interrupted antiretroviral therapy in British Columbia, Canada.
    J Acquir Immune Defic Syndr. 2022 Jan 10. pii: 00126334-900000000-95714.
    >> Share

  210. STARBUCK L, Golub SA, Klein A, Harris AB, et al
    Transgender Women and PrEP Care: High PrEP Adherence in a Real-World Health Care Setting in New York City.
    J Acquir Immune Defic Syndr. 2022 Jan 10. pii: 00126334-900000000-95713.
    >> Share

  211. DONENBERG GR, Fitts J, Ingabire C, Nsanzimana S, et al
    Results of the Kigali Imbereheza Project: A 2-arm individually randomized trial of TI-CBT enhanced to address ART adherence and mental health for Rwandan youth living with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 8. pii: 00126334-900000000-95715.
    >> Share

  212. TORDOFF DM, Zangeneh S, Khosropour CM, Glick SN, et al
    Geographic variation in HIV testing among transgender and non-binary adults in the US.
    J Acquir Immune Defic Syndr. 2022 Jan 7. pii: 00126334-900000000-95718.
    >> Share

  213. HILEMAN CO, Bowman ER, Gabriel J, Kettelhut A, et al
    Impact of Heroin and HIV on Gut Integrity and Immune Activation.
    J Acquir Immune Defic Syndr. 2022 Jan 7. pii: 00126334-900000000-95717.
    >> Share

  214. LUU BR, Nance RM, Delaney JAC, Ruderman SA, et al
    Insomnia and Risk of Myocardial Infarction Among People with HIV.
    J Acquir Immune Defic Syndr. 2022 Jan 6. pii: 00126334-900000000-95719.
    >> Share

  215. MAYER KH, Gelman M, Holmes J, Kraft J, et al
    Safety and Tolerability of Once Daily Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Post-Exposure Prophylaxis after Sexual Exposure.
    J Acquir Immune Defic Syndr. 2022 Jan 4. pii: 00126334-900000000-95720.
    >> Share

  216. ENDER PT, Markson RH, Suri A, Ruppert K, et al
    Rapid Implementation of a Telemedicine Program in a Ryan White-Funded HIV Clinic During a Global Pandemic.
    J Acquir Immune Defic Syndr. 2022;89:e2-e4.
    >> Share

  217. GAFF J, Estiasari R, Diafiri D, Halstrom S, et al
    Brief Report: Polymorphisms in CAMKK2 may Influence Domain-Specific Neurocognitive Function in HIV+ Indonesians Receiving ART.
    J Acquir Immune Defic Syndr. 2022;89:115-119.
    >> Share

  218. OUATTARA LA, Thurman AR, Jacot TA, Cottrell M, et al
    Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration.
    J Acquir Immune Defic Syndr. 2022;89:87-97.
    >> Share

  219. MEYER-MYKLESTAD MH, Medhus AW, Stiksrud B, Lorvik KB, et al
    Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum.
    J Acquir Immune Defic Syndr. 2022;89:77-86.
    >> Share

  220. ATTIA EF, Moraa H, Maleche-Obimbo E, Wamalwa D, et al
    Most Early-Treated Children With Perinatally Acquired HIV Have Preserved Lung Function at School Age.
    J Acquir Immune Defic Syndr. 2022;89:69-76.
    >> Share

  221. MBEWE EG, Kabundula PP, Mwanza-Kabaghe S, Buda A, et al
    Socioeconomic Status and Cognitive Function in Children With HIV: Evidence From the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.
    J Acquir Immune Defic Syndr. 2022;89:56-63.
    >> Share

  222. RAGONNET-CRONIN M, Hayford C, D'Aquila R, Ma F, et al
    Forecasting HIV-1 Genetic Cluster Growth in Illinois,United States.
    J Acquir Immune Defic Syndr. 2022;89:49-55.
    >> Share

  223. MANN LM, Kelley CF, Siegler AJ, Stephenson R, et al
    Seroadaptive Strategy Patterns of Young Black Gay, Bisexual, and Other Men Who Have Sex With Men in Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2022;89:40-48.
    >> Share

  224. QIAN Y, Moore RD, Coburn SB, Davy-Mendez T, et al
    Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD.
    J Acquir Immune Defic Syndr. 2022;89:9-18.
    >> Share

  225. D'SOUZA G, Tong W, Gustafson D, Alcaide ML, et al
    SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    J Acquir Immune Defic Syndr. 2022;89:1-8.
    >> Share

  226. PISCITELLI J, Nikanjam M, Best BM, Acosta E, et al
    Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and Simulation.
    J Acquir Immune Defic Syndr. 2022;89:108-114.
    >> Share

  227. LARSEN A, Abuna F, Owiti G, Kemunto V, et al
    Improving Quality of PrEP Counseling for Adolescent Girls and Young Women in Kenya With Standardized Patient Actors: A Dose-Response Analysis.
    J Acquir Immune Defic Syndr. 2022;89:34-39.
    >> Share

    December 2021
  228. DIJKSTRA S, Hofstra LM, Mudrikova T, Wensing AMJ, et al
    Lower incidence of HIV-1 blips observed during integrase inhibitor-based combination antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95731.
    >> Share

  229. ARIMIDE DA, Amogne MD, Kebede Y, Balcha TT, et al
    High level of HIV drug resistance and virological non-suppression among female sex workers in Ethiopia: a nation-wide cross-sectional study.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95730.
    >> Share

  230. JIANG H, Lan G, Zhu Q, Feng Y, et al
    Impacts Of HIV-1 Subtype Diversity on Long-Term Clinical Outcomes in Antiretroviral Therapy in Guangxi, China.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95729.
    >> Share

  231. KILGORE CB, Strain JF, Nelson B, Cooley SA, et al
    Cardiorespiratory Fitness is Associated with Better White Matter Integrity in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Dec 24. pii: 00126334-900000000-95728.
    >> Share

  232. MUJUGIRA A, Nakyanzi A, Nabaggala MS, Muwonge TR, et al
    Effect of HIV Self-Testing on PrEP Adherence among Gender Diverse Sex Workers in Uganda: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2021 Dec 23. pii: 00126334-900000000-95734.
    >> Share

  233. RIAL-CRESTELO D, Bisbal O, Font R, De Lagarde M, et al
    Incidence and severity of SARS-CoV-2 infection in HIV-infected individuals during the first year of the pandemic.
    J Acquir Immune Defic Syndr. 2021 Dec 23. pii: 00126334-900000000-95733.
    >> Share

  234. KING EM, Kaida A, Mayer U, Albert A, et al
    Undertreated midlife symptoms for women living with HIV linked to lack of menopause discussions with providers.
    J Acquir Immune Defic Syndr. 2021 Dec 23. pii: 00126334-900000000-95732.
    >> Share

  235. WANG Y, Karver TS, Barrington C, Donastorg Y, et al
    Structural and psychosocial impacts of the COVID-19 pandemic on HIV care and treatment outcomes among female sex workers in the Dominican Republic.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95727.
    >> Share

  236. VIOLETTE LR, Cornelius-Hudson A, Snidarich M, Niemann LA, et al
    Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95726.
    >> Share

  237. GOLDEN MR, AugsJoost B, Bender M, Brady KA, et al
    The Organization, Content, and Case-finding Effectiveness of HIV Assisted Partner Services in High HIV Morbidity Areas of the U.S.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95725.
    >> Share

  238. SACK DE, Gange SJ, Althoff KN, Pettit AC, et al
    Visualizing the geography of HIV observational cohorts with density-adjusted cartograms.
    J Acquir Immune Defic Syndr. 2021 Dec 21. pii: 00126334-900000000-95724.
    >> Share

  239. TAKUVA S, Karuna ST, Juraska M, Rudnicki E, et al
    Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b Antibody Mediated Prevention (AMP) randomized trials.
    J Acquir Immune Defic Syndr. 2021 Dec 20. pii: 00126334-900000000-95735.
    >> Share

  240. HETTA G, Jane M, Michelle H, Anna D, et al
    Impact of HIV on Cognitive Performance in Professional Drivers.
    J Acquir Immune Defic Syndr. 2021 Dec 20. pii: 00126334-900000000-95723.
    >> Share

  241. KRENISKE P, Nalugoda F, Chen I, Huang R, et al
    Mobile phones, sexual behaviors and HIV incidence in Rakai, Uganda from 2010-2018.
    J Acquir Immune Defic Syndr. 2021 Dec 20. pii: 00126334-900000000-95721.
    >> Share

  242. WILSON EC, Turner CM, Sanz-Rodriguez C, Arayasirikul S, et al
    Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  243. SEVELIUS JM, Glidden DV, Deutsch M, Welborn L, et al
    Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  244. RICE E, Wilder B, Onasch-Vera L, DiGuiseppi G, et al
    A Peer-Led, Artificial Intelligence-Augmented Social Network Intervention to Prevent HIV Among Youth Experiencing Homelessness.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  245. HOLLOWAY IW, Beltran R, Shah SV, Cordero L, et al
    Structural Syndemics and Antiretroviral Medication Adherence Among Black Sexual Minority Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  246. ARNOLD EA, Saberi P, Wong JO, Pollack LM, et al
    We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  247. LIGHTFOOT M, Milburn N, Loeb Stanga L
    Addressing Health Disparities in HIV: Introduction to the Special Issue.
    J Acquir Immune Defic Syndr. 2021;88.
    >> Share

  248. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;88:518-527.
    >> Share

  249. SUPANAN R, Han WM, Harnpariphan W, Ueaphongsukkit T, et al
    Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
    J Acquir Immune Defic Syndr. 2021;88:465-469.
    >> Share

  250. WAGNER Z, Mukasa B, Nakakande J, Stecher C, et al
    Impact of the COVID-19 Pandemic on Use of HIV Care, Antiretroviral Therapy Adherence, and Viral Suppression: An Observational Cohort Study From Uganda.
    J Acquir Immune Defic Syndr. 2021;88:448-456.
    >> Share

  251. FRIEDMAN MR, Kempf MC, Benning L, Adimora AA, et al
    Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women.
    J Acquir Immune Defic Syndr. 2021;88:426-438.
    >> Share

  252. EKSTRAND ML, Heylen E, Gandhi M, Steward WT, et al
    COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.
    J Acquir Immune Defic Syndr. 2021;88:421-425.
    >> Share

  253. LOPES J, Grimwood A, Ngorima-Mabhena N, Tiam A, et al
    Out-of-Facility Multimonth Dispensing of Antiretroviral Treatment: A Pooled Analysis Using Individual Patient Data From Cluster-Randomized Trials in Southern Africa.
    J Acquir Immune Defic Syndr. 2021;88:477-486.
    >> Share

  254. KANG M, Umbleja T, Ellsworth G, Aberg J, et al
    Effects of Sex, Existing Antibodies, and HIV-1 Related and Other Baseline Factors on Antibody Responses to Quadrivalent HPV Vaccine in Persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Dec 14. pii: 00126334-900000000-95739.
    >> Share

  255. BEHRENS GMN, Aebi-Popp K, Babiker A
    Close to zero, but not zero: What is an acceptable HIV transmission risk through breastfeeding?
    J Acquir Immune Defic Syndr. 2021 Dec 10. pii: 00126334-900000000-95742.
    >> Share

  256. D'ANTONI ML, Andreatta K, Acosta R, Martin H, et al
    Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials.
    J Acquir Immune Defic Syndr. 2021 Dec 10. pii: 00126334-900000000-95741.
    >> Share

  257. GONZALES P, Bachireddy C, Grieco A, Ding R, et al
    Viral Suppression Levels in Newly Diagnosed Men Who Have Sex with Men and Transgender Women with Newly Diagnosed HIV and Alcohol Use Disorder in Peru: Results from a Randomized, Double-Blind, Placebo-Controlled Trial Using Oral Naltrexone.
    J Acquir Immune Defic Syndr. 2021 Dec 10. pii: 00126334-900000000-95740.
    >> Share

  258. ABUOGI LL, Castillo-Mancilla J, Hampanda K, Owuor K, et al
    Tenofovir Diphosphate in Dried Blood Spots in pregnant and postpartum women with HIV in Kenya: a novel approach to measuring peripartum adherence.
    J Acquir Immune Defic Syndr. 2021 Dec 9. pii: 00126334-900000000-95743.
    >> Share

  259. TITANJI BK, Tejani M, Farber EW, Mehta CC, et al
    Cognitively-Based Compassion Training for HIV Immune Non-responders - An Attention-Placebo Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2021 Dec 7. pii: 00126334-900000000-95752.
    >> Share

  260. BIEN-GUND CH, Bilker W, Schnoll RA, Tyndale RF, et al
    Nicotine metabolism ratio increases in HIV-positive smokers on effective antiretroviral therapy: a cohort study.
    J Acquir Immune Defic Syndr. 2021 Dec 7. pii: 00126334-900000000-95751.
    >> Share

  261. BEKKER A, Rabie H, Salvadori N, du Toit S, et al
    Pharmacokinetics and safety of the abacavir/lamivudine/lopinavir/ritonavir fixed-dose granule formulation (4-in-1) in neonates: PETITE study.
    J Acquir Immune Defic Syndr. 2021 Dec 2. pii: 00126334-900000000-95754.
    >> Share

  262. BATES L, Honeycutt A, Bass S, Green TA, et al
    Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2021;88:e28-e30.
    >> Share

  263. KOAY WLA, Prabhakar S, Neilan A, Meyers J, et al
    Brief Report: Supporting Access to HIV Care for Children and Youth During the COVID-19 Pandemic With Telemedicine and Rideshare.
    J Acquir Immune Defic Syndr. 2021;88:384-388.
    >> Share

  264. REES H, Chersich MF, Munthali RJ, Brumskine W, et al
    HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
    J Acquir Immune Defic Syndr. 2021;88:376-383.
    >> Share

    November 2021
  265. GROVES AK, Bhushan NL, Stoner MCD, Gomez-Olive FX, et al
    HIV and HSV-2 incidence among Adolescent Mothers in South Africa: A Longitudinal Analysis of HIV Prevention Trials Network 068 Data.
    J Acquir Immune Defic Syndr. 2021 Nov 25. pii: 00126334-900000000-95755.
    >> Share

  266. CARLUCCI JG, De Schacht C, Graves E, Gonzalez P, et al
    CD4 Trends with Evolving Treatment Initiation Policies among Children Living with HIV in Zambezia Province, Mozambique, 2012-2018.
    J Acquir Immune Defic Syndr. 2021 Nov 24. pii: 00126334-900000000-95758.
    >> Share

  267. DONG T, Rana MN, Longenecker CT, Rajagopalan S, et al
    Machine Learning Estimation of Low-Density Lipoprotein Cholesterol in Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Nov 22. pii: 00126334-900000000-95759.
    >> Share

  268. CHAI PR, Mohamed Y, Bustamante MJ, Goodman GR, et al
    DigiPrEP: A pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95762.
    >> Share

  269. CAPOFERRI AA, Redd AD, Gocke CD, Clark LR, et al
    Rebound HIV viremia with meningoencephalitis following antiretroviral therapy interruption after allogeneic bone marrow transplant.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95761.
    >> Share

  270. CALZA L, Legnani G, Fulgaro C, Verucchi G, et al
    CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR.
    J Acquir Immune Defic Syndr. 2021 Nov 5. pii: 00126334-900000000-95763.
    >> Share

  271. FONG Y, Markby J, Andreotti M, Beck I, et al
    Diagnostic accuracy of dried plasma spot specimens for HIV-1 viral load testing: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95767.
    >> Share

  272. OPOLLO V, Nyakeriga E, Kingwara L, Sila A, et al
    Evaluation of the Performance of OraQuick(R) Rapid HIV-1/2 Test among decedents in Kisumu, Kenya.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95766.
    >> Share

  273. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95765.
    >> Share

  274. MATTHEWS RP, Jackson Rudd D, Zhang S, Fillgrove KL, et al
    Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV.
    J Acquir Immune Defic Syndr. 2021;88:314-321.
    >> Share

  275. GIACOMELLI A, Bonazzetti C, Conti F, Pezzati L, et al
    Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic.
    J Acquir Immune Defic Syndr. 2021;88:299-304.
    >> Share

  276. KATUREEBE C, Ashburn K, Machekano R, Gill MM, et al
    Developing and Validating an Effective Pediatric and Adolescent HIV Testing Eligibility Screening Tool for High-Volume Entry Points in Uganda.
    J Acquir Immune Defic Syndr. 2021;88:290-298.
    >> Share

  277. ZHU W, Huang YA, Kourtis AP, Hoover KW, et al
    Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2021;88:282-289.
    >> Share

  278. DAUBERT E, French AL, Burgess HJ, Sharma A, et al
    Association of poor sleep with depressive and anxiety symptoms by HIV disease status: Women's Interagency HIV Study (WIHS).
    J Acquir Immune Defic Syndr. 2021 Nov 1. pii: 00126334-900000000-95764.
    >> Share

    October 2021
  279. HOJILLA JC, Hurley LB, Marcus JL, Satre DD, et al
    The HIV preexposure prophylaxis (PrEP) continuum of care among transgender individuals in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95770.
    >> Share

  280. SAXBY K, Chan C, Bavinton BR
    Structural stigma and sexual health disparities among gay, bisexual, and other men who have sex with men in Australia.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95769.
    >> Share

  281. NYANDIKO W, Holland S, Vreeman R, DeLong AK, et al
    HIV-1 Treatment Failure, Drug Resistance and Clinical Outcomes in Perinatally-Infected Children and Adolescents Failing 1st-Line Antiretroviral Therapy in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95768.
    >> Share

  282. GIBBS A, Reddy T, Closson K, Cawood C, et al
    Intimate partner violence and the HIV care and treatment cascade among adolescent girls and young women in DREAMS, South Africa.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95776.
    >> Share

  283. ZANG X, Mah C, Linh Quan AM, Min JE, et al
    Human Immunodeficiency Virus transmission by HIV risk group and along the HIV care continuum: A contrast of six US cities.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95775.
    >> Share

  284. SYED MA, Khan A, Chaudhry A, Baig MA, et al
    An Epidemic of Pediatric HIV from Reuse of Infusion Equipment in Pakistan.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95774.
    >> Share

  285. VOLPE LJ, Powis KM, Legbedze J, Sun S, et al
    A counseling and monitoring approach for supporting breastfeeding women living with HIV in Botswana.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95773.
    >> Share

  286. CONROY AA, Jain JP, Sheira L, Frongillo EA, et al
    Mental Health Mediates the Association between Gender-Based Violence and HIV Treatment Engagement in U.S. Women.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95772.
    >> Share

  287. SUEN LW, Davidson PJ, Browne EN, Lambdin BH, et al
    Effect of an Unsanctioned Safe Consumption Site in the United States on Syringe Sharing, Rushed Injections, and Isolated Injection Drug Use: A Longitudinal Cohort Analysis.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95771.
    >> Share

  288. NANYONGA SM, Kitutu FE, Kalyango J, Frank M, et al
    High burden of adverse drug reactions to Isoniazid Preventive Therapy in people living with HIV at three tertiary hospitals in Uganda: associated factors.
    J Acquir Immune Defic Syndr. 2021 Oct 21. pii: 00126334-900000000-95777.
    >> Share

  289. ROUSSEAU RK, Walmsley SL, Lee T, Rosenes R, et al
    A randomized, blinded, placebo-controlled trial of De Simone formulation probiotic during HIV-associated suboptimal CD4+ T cell recovery.
    J Acquir Immune Defic Syndr. 2021 Oct 20. pii: 00126334-900000000-95779.
    >> Share

  290. SHAFFER D, Kumwenda J, Chen H, Akelo V, et al
    Brief Report: No Differences Between Lopinavir/ritonavir and non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)
    J Acquir Immune Defic Syndr. 2021 Oct 19. pii: 00126334-900000000-95780.
    >> Share

  291. SAHAGUN SJ, Yeramosu T, Purdy JB, Reynolds JC, et al
    Associations between Central Obesity and Life-Long Antiviral Therapy in Adults Living with HIV Acquired from Early Childhood.
    J Acquir Immune Defic Syndr. 2021 Oct 19. pii: 00126334-900000000-95778.
    >> Share

  292. SCHURMANN D, Rudd DJ, Schaeffer A, De Lepeleire I, et al
    Single oral doses of MK-8507, a novel non-nucleoside reverse transcriptase inhibitor, suppress HIV-1 RNA for a week.
    J Acquir Immune Defic Syndr. 2021 Oct 13. pii: 00126334-900000000-95781.
    >> Share

  293. PYRA M, Brewer R, Rusie L, Kline J, et al
    Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    J Acquir Immune Defic Syndr. 2021 Oct 9. pii: 00126334-900000000-95782.
    >> Share

  294. LONGINO AA, Paul R, Wang Y, Lama JR, et al
    HIV disease dynamics, markers of inflammation and CNS injury during primary HIV infection and their relationship to cognitive performance.
    J Acquir Immune Defic Syndr. 2021 Oct 7. pii: 00126334-900000000-95788.
    >> Share

  295. TRUJILLO L, Robbins T, Morris E, Sionean C, et al
    Material hardship and association with sexual risk behavior among adolescent sexual minority males in 3 U.S. cities - National HIV Behavioral Surveillance-Young Men who Have Sex with Men, 2015.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95789.
    >> Share

  296. KAPLAN SR, Escudero JN, Mecha J, Richardson BA, et al
    Interferon gamma release-assay and tuberculin skin test performance in pregnant women living with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95787.
    >> Share

  297. DIAZ RS, Grangeiro A, Estevam DL, Galinskas J, et al
    Pre-exposure prophylaxis failure with a multiple drug-resistant HIV-1 clade C virus in Brazil.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95786.
    >> Share

  298. FAZELI PL, Woods SP, Lambert CC, Li W, et al
    Differential Associations Between BDNF and Memory Across Older Black and White Adults with HIV Disease.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95784.
    >> Share

  299. HELLER T, Wallrauch C, Gumulira J, Rambiki K, et al
    Low CD4 counts despite effective ART in hospitalized Malawian HIV+/COVID+ co-infected patients.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95783.
    >> Share

  300. DELLE DONNE V, Massaroni V, Ciccarelli N, Lombardi F, et al
    Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:e11-e14.
    >> Share

  301. ALESSANDRI-GRADT E, Unal G, Baron A, Leoz M, et al
    Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants.
    J Acquir Immune Defic Syndr. 2021;88:220-227.
    >> Share

  302. CAMPBELL L, Barbini B, Burling K, Cromarty B, et al
    Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2021;88:214-219.
    >> Share

  303. WOMACK JA, Murphy TE, Ramsey C, Bathulapalli H, et al
    Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?
    J Acquir Immune Defic Syndr. 2021;88:192-196.
    >> Share

  304. HULL SJ, Tessema H, Thuku J, Scott RK, et al
    Providers PrEP: Identifying Primary Health care Providers' Biases as Barriers to Provision of Equitable PrEP Services.
    J Acquir Immune Defic Syndr. 2021;88:165-172.
    >> Share

  305. LEMOS MP, Nandi V, Dragavon J, Fleming I, et al
    HIV-1 Nucleic Acids Identify Rectal HIV Exposures in Self-Collected Rectal Swabs, Whereas Y-Chromosome Single Tandem Repeat Mixtures Are Not Reliable Biomarkers of Condomless Receptive Anal Intercourse.
    J Acquir Immune Defic Syndr. 2021;88:138-148.
    >> Share

  306. GROV C, Patel VV, D'Angelo AB, Zohra F, et al
    Close, But Not Quite: One in Twenty Trans and Gender Diverse Individuals Assigned Female at Birth Are Being Prescribed the Wrong Kind of PrEP.
    J Acquir Immune Defic Syndr. 2021;88:e10-e11.
    >> Share

  307. VICTOR O, Phiona M, Vernon M, Thoko M, et al
    Adverse Event Trends Within a Large-Scale, Routine, Voluntary Medical Male Circumcision Program in Zimbabwe, 2014-2019.
    J Acquir Immune Defic Syndr. 2021;88:173-180.
    >> Share

    September 2021
  308. ERLY S, Khosropour CM, Hajat A, Sharma M, et al
    Characterization of the Population Impacted by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr. 2021 Sep 30. pii: 00126334-900000000-95790.
    >> Share

  309. RAJU S, Astemborski J, Drummond MB, Ramamurthi HC, et al
    HIV is Associated with Impaired Pulmonary Diffusing Capacity Independent of Emphysema.
    J Acquir Immune Defic Syndr. 2021 Sep 24. pii: 00126334-900000000-95797.
    >> Share

  310. AUNG S, Hardy N, Chrysanthopoulou SA, Kyaw A, et al
    Stigma Determines Antiretroviral Adherence in Adults with HIV in Myanmar.
    J Acquir Immune Defic Syndr. 2021 Sep 17. pii: 00126334-900000000-95804.
    >> Share

  311. MURNANE PM, Ayieko J, Vittinghoff E, Gandhi M, et al
    Machine learning algorithms using routinely collected data do not adequately predict viremia to inform targeted services in postpartum women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95807.
    >> Share

  312. HOGH J, Gelpi M, Skovsgaard MH, Afzal S, et al
    HIV infection is associated with type 2 diabetes mellitus.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95806.
    >> Share

  313. SORENSEN EW, Gelpi M, Knudsen AD, Benfield T, et al
    Switch To Insti, But Not Long-Term Stable Insti, Is Associated With Excess Weight Gain In People Living With Hiv.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95805.
    >> Share

  314. KERSCHBERGER B, Aung A, Mpala Q, Ntshalintshali N, et al
    Predicting, diagnosing and treating acute and early HIV infection in a public sector facility in Eswatini.
    J Acquir Immune Defic Syndr. 2021 Sep 3. pii: 00126334-900000000-95815.
    >> Share

  315. HAGINS D, Kumar P, Saag M, Wurapa AK, et al
    Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.
    J Acquir Immune Defic Syndr. 2021;88:86-95.
    >> Share

  316. GUTIERREZ J, Porras TN, Yoo-Jeong M, Khasiyev F, et al
    Cerebrovascular Contributions to Neurocognitive Disorders in People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:79-85.
    >> Share

  317. MOLDT B, Parvangada A, Martin R, Pace C, et al
    Evaluation of Broadly Neutralizing Antibody Sensitivity by Genotyping and Phenotyping for Qualifying Participants to HIV Clinical Trials.
    J Acquir Immune Defic Syndr. 2021;88:61-69.
    >> Share

  318. SEWELL WC, Powell VE, Ball-Burack M, Mayer KH, et al
    Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care.
    J Acquir Immune Defic Syndr. 2021;88:31-35.
    >> Share

  319. MALONE J, Reisner SL, Cooney EE, Poteat T, et al
    Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
    J Acquir Immune Defic Syndr. 2021;88:10-18.
    >> Share

  320. CHANG JJ, Bruxvoort K, Chen LH, Akhavan B, et al
    Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System.
    J Acquir Immune Defic Syndr. 2021;88:1-5.
    >> Share

  321. SARDA V, Gomez C, Soria J, Sarmiento J, et al
    Factors Associated With Coronavirus Disease 2019 Morbidity in a Cohort of People Living With Human Immunodeficiency Virus.
    J Acquir Immune Defic Syndr. 2021;88:e7-e9.
    >> Share

  322. CICCULLO A, D'Angelillo A, Iannone V, Farinacci D, et al
    Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV.
    J Acquir Immune Defic Syndr. 2021;88:e5-e6.
    >> Share

    August 2021
  323. BENNETT CL, Ogele E, Pettit NR, Bischof JJ, et al
    Multi-Center Study of Outcomes Among Persons with HIV who Presented to US Emergency Departments with suspected SARS-CoV-2.
    J Acquir Immune Defic Syndr. 2021 Aug 31. pii: 00126334-900000000-95816.
    >> Share

  324. BROWN LK, Chernoff M, Kennard BD, Emslie GJ, et al
    Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States.
    J Acquir Immune Defic Syndr. 2021 Aug 30. pii: 00126334-900000000-95818.
    >> Share

  325. TEMBO TA, Simon KR, Kim MH, Chikoti C, et al
    Pilot-testing a Blended Learning Package for Health Care Workers to Improve Index Testing Services in Southern Malawi: An Implementation Science Study.
    J Acquir Immune Defic Syndr. 2021 Aug 30. pii: 00126334-900000000-95817.
    >> Share

  326. NGURE K, Mugo NR, Bukusi EA, Kiptinness C, et al
    Pills, injections, rings or implants? PrEP formulation preferences of PrEP-experienced African women for HIV prevention.
    J Acquir Immune Defic Syndr. 2021 Aug 25. pii: 00126334-900000000-95819.
    >> Share

  327. DAT VQ, Lyss S, Hoai Dung NT, Hung LM, et al
    Prevalence of advanced HIV disease, cryptococcal antigenemia and suboptimal clinical outcomes among those enrolled in care in Vietnam.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95822.
    >> Share

  328. MCCREE DH, Beer L, Jeffries WL 4th, Tie Y, et al
    Sociodemographic Correlates of Self-reported Discrimination in HIV Health Care Settings among Persons with Diagnosed HIV in the United States, Medical Monitoring Project, 2018-2019.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95821.
    >> Share

  329. CICCULLO A, Borghi V, Giacomelli A, Cossu MV, et al
    Five years with dolutegravir plus lamivudine as a switch strategy: much more than a positive finding.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95820.
    >> Share

  330. ORKIN C, Ajana F, Kityo C, Koenig E, et al
    Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95811.
    >> Share

  331. KRENISKE P, Mellins CA, Dolezal C, Morrison C, et al
    Predictors of attempted suicide among youth living with perinatal HIV infection and perinatal HIV exposed uninfected counterparts.
    J Acquir Immune Defic Syndr. 2021 Aug 16. pii: 00126334-900000000-95824.
    >> Share

  332. LUCKETT PH, Paul RH, Hannon K, Lee JJ, et al
    Modeling the Effects of HIV and Aging on Resting-State Networks using Machine Learning.
    J Acquir Immune Defic Syndr. 2021 Aug 16. pii: 00126334-900000000-95823.
    >> Share

  333. MUCCINI C, Pinyakorn S, Sirivichayakul S, Kroon E, et al
    Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2021;87:1173-1177.
    >> Share

  334. FISHER MC, Fazzari MJ, Hanna DB, Patel VV, et al
    Brief Report: Acute Kidney Injury in People Living With HIV Hospitalized With Coronavirus Disease 2019: Clinical Characteristics and Outcomes.
    J Acquir Immune Defic Syndr. 2021;87:1167-1172.
    >> Share

  335. GILLES I, Lesage S, Barbieux C, Alessandrini M, et al
    Brief Report: Representations and Willingness of People Living With HIV in Switzerland to Participate in HIV Cure Trials: The Case of Gene-Modified Cell Therapies.
    J Acquir Immune Defic Syndr. 2021;87:1154-1160.
    >> Share

  336. JONGEN VW, Zimmermann HML, Boyd A, Hoornenborg E, et al
    Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2021;87:1111-1118.
    >> Share

  337. DETTINGER JC, Pintye J, Dollah A, Awuor M, et al
    "What is this PrEP?"- Sources and accuracy of HIV Pre-Exposure Prophylaxis (PrEP) awareness among adolescent girls and young women attending family planning and maternal child health clinics in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Aug 9. pii: 00126334-900000000-95825.
    >> Share

  338. FRENKEL LM, Leavitt Morrison R, Fuller TL, Isabel Gouvea M, et al
    Vaginal Viral Shedding with Undetectable Plasma HIV Viral Load in Pregnant Women Receiving Two Different Antiretroviral Regimens: A Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2021 Aug 7. pii: 00126334-900000000-95826.
    >> Share

  339. LE GUILLOU A, Buchbinder S, Scott H, Liu A, et al
    Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage among San Francisco Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95830.
    >> Share

  340. WIGGILL T, Mayne E, Perner Y, Vaughan J, et al
    Changing patterns of Lymphoma in the Anti-Retroviral Therapy Era in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95829.
    >> Share

  341. BROPHY JE, Lessler J, Ssekubugu R, Kennedy CE, et al
    Prevalence of untreated HIV and associated risk behaviors among the sexual partners of recent migrants and long-term residents in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95828.
    >> Share

  342. DAILEY A, Johnson AS, Hu X, Gant Z, et al
    Trends in HIV Care Outcomes Among Adults and Adolescents - 33 Jurisdictions, United States, 2014-2018.
    J Acquir Immune Defic Syndr. 2021 Aug 4. pii: 00126334-900000000-95827.
    >> Share

  343. WEST CA, Chang GC, W Currie D, Bray R, et al
    Unawareness of HIV Infection Among Men Aged 15-59 Years in 13 Sub-Saharan African Countries: Findings From the Population-Based HIV Impact Assessments, 2015-2019.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  344. VOETSCH AC, Duong YT, Stupp P, Saito S, et al
    HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  345. DOMAOAL RA, Sleeman K, Sawadogo S, Dzinamarira T, et al
    Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  346. BRAY R, Palma AM, Philip NM, Brown K, et al
    Is Interview Length Associated With Blood Test Participation? Evidence From Three Population-Based HIV Impact Assessment Surveys Conducted From 2016 to 2017.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  347. REID G, Voetsch AC, Stupp P, McCracken S, et al
    Improving Sampling Efficiency for Determining Pediatric HIV Prevalence in National Surveys: Evidence From 8 Sub-Saharan African Countries.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  348. JAHUN I, Greby SM, Adesina T, Agbakwuru C, et al
    Lessons From Rapid Field Implementation of an HIV Population-Based Survey in Nigeria, 2018.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  349. METZ M, Smith R, Mitchell R, Duong YT, et al
    Data Architecture to Support Real-Time Data Analytics for the Population-Based HIV Impact Assessments.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  350. PATEL HK, Duong YT, Birhanu S, Dobbs T, et al
    A Comprehensive Approach to Assuring Quality of Laboratory Testing in HIV Surveys: Lessons Learned From the Population-Based HIV Impact Assessment Project.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  351. SACHATHEP K, Radin E, Hladik W, Hakim A, et al
    Population-Based HIV Impact Assessments Survey Methods, Response, and Quality in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  352. PORTER L, Bello G, Nkambule R, Justman J, et al
    HIV General Population Surveys: Shedding Light on the Status of HIV Epidemics and Informing Future Actions.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  353. HOQUE TMD, Cattin A, Whyte-Allman SK, Winchester L, et al
    Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2021;87:1093-1101.
    >> Share

  354. TAIWO BO, Kuti KM, Kuhns LM, Omigbodun O, et al
    Effect of Text Messaging Plus Peer Navigation on Viral Suppression Among Youth With HIV in the iCARE Nigeria Pilot Study.
    J Acquir Immune Defic Syndr. 2021;87:1086-1092.
    >> Share

  355. SAMBOJU V, Cobigo Y, Paul R, Naasan G, et al
    Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;87:1079-1085.
    >> Share

  356. HERMANS LE, Nijhuis M, Tempelman HA, Houts T, et al
    Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study.
    J Acquir Immune Defic Syndr. 2021;87:1072-1078.
    >> Share

  357. BIRX D, Zaidi I
    Forward: Measuring Progress Toward Epidemic Control.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

    July 2021
  358. SHRADER CH, Arroyo-Flores J, Stoler J, Skvoretz J, et al
    The association between social and spatial closeness with PrEP conversations among Latino men who have sex with men.
    J Acquir Immune Defic Syndr. 2021 Jul 31. pii: 00126334-900000000-95832.
    >> Share

  359. KAMIS KF, Barbera L, Abdo M, Rowan SE, et al
    Risk factors for hospitalization in people with HIV and COVID-19.
    J Acquir Immune Defic Syndr. 2021 Jul 30. pii: 00126334-900000000-95834.
    >> Share

  360. CHAISSON LH, Saraceni V, Cohn S, Cavalcante SC, et al
    Yield of repeat tuberculin skin testing for people living with HIV in Brazil.
    J Acquir Immune Defic Syndr. 2021 Jul 30. pii: 00126334-900000000-95833.
    >> Share

  361. KOUSARI A, Moser C, Olefsky M, Brown TT, et al
    Poorer Muscle Quality and Quantity with ART Initiation is Associated with Greater Inflammation and Immune Activation.
    J Acquir Immune Defic Syndr. 2021 Jul 28. pii: 00126334-900000000-95835.
    >> Share

  362. SCHLENKER NW, Irvin NA, Galetto GG, Dashler GM, et al
    Identifying Missed Opportunities in the Prevention of Acute HIV Infection - The Need to Provide Pre-Exposure Prophylaxis Referrals to Emergency Department Patients with Increased Risk for Acquiring HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 27. pii: 00126334-900000000-95836.
    >> Share

  363. HAKIM AJ, Tippett Barr BA, Kinchen S, Musuka G, et al
    Progress toward the 90-90-90 HIV targets in Zimbabwe and identifying those left behind.
    J Acquir Immune Defic Syndr. 2021 Jul 24. pii: 00126334-900000000-95837.
    >> Share

  364. LYSS SB, Zhang T, Oster AM
    HIV Diagnoses Among Persons Who Inject Drugs, by Urban-Rural Classification - United States, 2010-2018.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95839.
    >> Share

  365. CHEN YT, Duncan DT, Del Vecchio N, Timmins L, et al
    COVID-19 related stressors, sex behaviors, and HIV status neutral care among Black men who have sex with men and transgender women in Chicago, USA.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95838.
    >> Share

  366. JOHNSTON CD, Siegler EL, Rice MC, Derry HM, et al
    Urine Cell-Free Mitochondrial DNA as a Marker of Weight Loss and Body Composition in Older Adults with HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95842.
    >> Share

  367. MANZA-A AGOVI A, Anikpo I, Cvitanovich M, Fasanmi EO, et al
    Brief Report: HIV Pre-Exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95841.
    >> Share

  368. SALAMA E, Hill L, Patel N, Best BM, et al
    Pharmacokinetics of bictegravir and tenofovir in combination with darunavir/cobicistat in treatment-experienced persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95840.
    >> Share

  369. COPELAND NK, Eller MA, Kim D, Creegan M, et al
    Increased Inflammation and Liver Disease in HIV/HBV-coinfected Individuals.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95846.
    >> Share

  370. CELERINO DA SILVA R, Pereira Alves NM, Gondim Silva ML, Agrelli A, et al
    Polymorphisms in TNF-alpha/TNFR1 pathway genes are associated with CD4+ T cells recovery in HIV-1-infected individuals on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95845.
    >> Share

  371. LARA-PAEZ G, Zuazo M, Blumenthal J, Coyne CJ, et al
    HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95844.
    >> Share

  372. KALICHMAN SC, Kalichman MO, Eaton LA
    Undisclosed HIV Status to Sex Partners and Its Unintended Consequences in the Era of Undetectable = Untransmittable.
    J Acquir Immune Defic Syndr. 2021 Jul 13. pii: 00126334-900000000-95843.
    >> Share

  373. LELLOUCHE L, Gutierrez LA, Leclercq P, Zaegel-Faucher O, et al
    Frailty in Aging People Living With HIV: a matched controlled Study.
    J Acquir Immune Defic Syndr. 2021 Jul 6. pii: 00126334-900000000-95850.
    >> Share

  374. LUAN H, Song I, Fiellin DA, Ransome Y, et al
    HIV infection prevalence significantly intersects with COVID-19 infection at the area-level: a USA county-level analysis.
    J Acquir Immune Defic Syndr. 2021 Jul 6. pii: 00126334-900000000-95849.
    >> Share

  375. ELLSWORTH GB, Stier EA, Chiao EY, Lensing SY, et al
    Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIV.
    J Acquir Immune Defic Syndr. 2021;87:978-984.
    >> Share

  376. GRANDE M, Mawandia S, Bakae O, Tau L, et al
    Intensified Assisted Partner Notification Implementation in Botswana Increased Partner Identification but Not HIV Case-Finding: Findings Highlight the Need for Improved Data Monitoring.
    J Acquir Immune Defic Syndr. 2021;87:951-958.
    >> Share

    June 2021
  377. GIACOMELLI A, Cozzi-Lepri A, Cingolani A, Tavelli A, et al
    Does syphilis increase the risk of HIV-RNA elevation >200 copies/mL in HIV positive patients under effective antiretroviral treatment? Data from the ICONA cohort.
    J Acquir Immune Defic Syndr. 2021 Jun 15. pii: 00126334-900000000-95862.
    >> Share

  378. PANTAZIS N, Rosinska M, VAN Sighem A, Quinten C, et al
    Discriminating between pre-migration and post-migration HIV acquisition using surveillance data.
    J Acquir Immune Defic Syndr. 2021 Jun 15. pii: 00126334-900000000-95861.
    >> Share

  379. EL-FAR M, Hanna DB, Durand M, Larouche-Anctil E, et al
    Subclinical carotid artery atherosclerosis is associated with increased expression of peripheral blood IL-32 isoforms among women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Jun 14. pii: 00126334-900000000-95860.
    >> Share

  380. SILHOL R, Coupland H, Baggaley RF, Miller L, et al
    What is the burden of heterosexually-acquired HIV due to HSV-2? Global and regional model-based estimates of the proportion and number of HIV infections attributable to HSV-2 infection.
    J Acquir Immune Defic Syndr. 2021 Jun 9. pii: 00126334-900000000-95864.
    >> Share

  381. FLYNN PM, Taha TE, Cababasay M, Butler K, et al
    Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Breastfeeding in the PROMISE Postpartum Component.
    J Acquir Immune Defic Syndr. 2021 Jun 8. pii: 00126334-900000000-95865.
    >> Share

  382. CHAWANA TD, Nhachi CFB, Nathoo K, Ngara B, et al
    Ritonavir concentrations in hair predict virologic outcomes in HIV-infected adolescents with virologic failure on atazanavir/ritonavir-based second-line treatment.
    J Acquir Immune Defic Syndr. 2021 Jun 8. pii: 00126334-900000000-95863.
    >> Share

  383. JONES DL, Morgan KE, Martinez PC, Rodriguez VJ, et al
    COVID-19 Burden and Risk Among People With HIV.
    J Acquir Immune Defic Syndr. 2021;87:869-874.
    >> Share

  384. DZIVA CHIKWARI C, Simms V, Kranzer K, Dringus S, et al
    Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests.
    J Acquir Immune Defic Syndr. 2021;87:781-788.
    >> Share

    May 2021
  385. VUYLSTEKE B, Reyniers T, Noestlinger C, Smekens T, et al
    Can we predict incorrect PrEP use in high HIV risk situations among Men who have Sex with Men? An analysis of Be-PrEP-ared, the Belgian PrEP demonstration study .
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95868.
    >> Share

  386. BILLOCK RM, Samoff E, Lund JL, Pence BW, et al
    HIV VIRAL SUPPRESSION AND PRE-EXPOSURE PROPHYLAXIS IN HIV AND SYPHILIS CONTACT TRACING NETWORKS: AN ANALYSIS OF DISEASE SURVEILLANCE AND PRESCRIPTION CLAIMS DATA.
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95867.
    >> Share

  387. GUZMAN VA, Cham H, Gutierrez J, Byrd D, et al
    The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95866.
    >> Share

  388. MCMILLAN JM, Gill MJ, Power C, Fujiwara E, et al
    Construct and Criterion-Related Validity of the Clinical Frailty Scale in Persons with HIV.
    J Acquir Immune Defic Syndr. 2021 May 28. pii: 00126334-900000000-95871.
    >> Share

  389. JASANTHA O, Kabanda S, Malaba TR, Lesosky M, et al
    Viral load monitoring in pregnancy to predict peripartum viraemia in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 28. pii: 00126334-900000000-95870.
    >> Share

  390. AMELIA DE SOUSA MASCENA VERAS , Roza Saggese GS, Gomez Junior JL, Silveira P, et al
    Young age and sex work are associated with HIV seroconversion among transgender women in Sao Paulo, Brazil.
    J Acquir Immune Defic Syndr. 2021 May 26. pii: 00126334-900000000-95872.
    >> Share

  391. GOENAGA SANCHEZ MA, Rodriguez IA, Equiza J, Echeverria CG, et al
    Prognosis of Stroke Among People Living with HIV and its relationship with admission to specialized Stroke Units.
    J Acquir Immune Defic Syndr. 2021 May 21. pii: 00126334-900000000-95876.
    >> Share

  392. HAZEN R, Halbur D, Mills B, Kirkham H, et al
    Evaluation of medication therapy issues, resolutions, and adherence among persons with HIV in the pharmacist-led Patient-centered HIV Care Model.
    J Acquir Immune Defic Syndr. 2021 May 20. pii: 00126334-900000000-95875.
    >> Share

  393. FOURMAN LT, Mueller SB, Boutin A, Zheng I, et al
    Placental Vascular Abnormalities in Association with Prenatal and Long-term Health Characteristics Among HIV-Exposed Uninfected Adolescents and Young Adults
    J Acquir Immune Defic Syndr. 2021 May 20. pii: 00126334-900000000-95874.
    >> Share

  394. HENSEN B, Machingura F, Busza J, Birdthistle I, et al
    How can we support the use of oral PrEP among young women who sell sex? A PrEP cascade analysis.
    J Acquir Immune Defic Syndr. 2021 May 19. pii: 00126334-900000000-95869.
    >> Share

  395. FOX MP, Pascoe S, Huber AN, Murphy J, et al
    Short-term Outcomes from a Cluster Randomized Evaluation of Adherence Clubs as Part of Differentiated HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95880.
    >> Share

  396. JOHNSON KA, Okochi H, Glidden DV, Gandhi M, et al
    Brief Report: No Difference in Urine Tenofovir Levels in Patients Living with HIV on Unboosted vs Dose-Adjusted Boosted Tenofovir Alafenamide.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95879.
    >> Share

  397. GRAHAM SM, Maqungo S, Laubscher M, Ferreira N, et al
    Fracture healing in patients with human immunodeficiency virus in South Africa: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95886.
    >> Share

  398. DRAIN PK, Galagan SR, Govere S, Krows M, et al
    Laboratory Reflex and Clinic-based Point-of-care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality among People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95885.
    >> Share

  399. DIAS JP, Haberlen SA, Dobs AS, Lake JE, et al
    Longitudinal changes in sex hormone-binding globulin in men with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95884.
    >> Share

  400. JIAMSAKUL A, Boyd M, Choi JY, Edmiston N, et al
    Trends in follow-up visits among people living with HIV - results from the TREAT Asia and Australian HIV Observational Databases (TAHOD and AHOD).
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95883.
    >> Share

  401. HESELTINE T, Murray S, Ortega-Martorell S, Olier I, et al
    Associations of Hepatosteatosis with Cardiovascular Disease in HIV Positive and HIV Negative Patients: The Liverpool HIV-Heart Project.
    J Acquir Immune Defic Syndr. 2021 May 8. pii: 00126334-900000000-95882.
    >> Share

  402. SIRAJEE R, Conroy AL, Namasopo S, Opoka RO, et al
    Growth Faltering and Developmental Delay in HIV-Exposed Uninfected Ugandan Infants: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;87:730-740.
    >> Share

  403. GAY CL, Bosch RJ, McKhann A, Moseley KF, et al
    Suspected Immune-Related Adverse Events with an Anti-PD-1 Inhibitor in Healthy People with HIV.
    J Acquir Immune Defic Syndr. 2021 May 1. pii: 00126334-900000000-95887.
    >> Share

    April 2021
  404. PITPITAN EV, MacKinnon DP, Eaton LA, Smith LR, et al
    Using novel approaches to evaluate behavioral interventions: Overlooked significant HIV prevention effects in HPTN 015 Project EXPLORE.
    J Acquir Immune Defic Syndr. 2021 Apr 20. pii: 00126334-900000000-95892.
    >> Share

  405. ANDERSON AM, Tang B, Vaida F, Mcclernon D, et al
    Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study.
    J Acquir Immune Defic Syndr. 2021 Apr 20. pii: 00126334-900000000-95891.
    >> Share

  406. SCHUMACHER CM, Tao X, Chandran A, Fields E, et al
    Reaching those most at risk for HIV acquisition: Evaluating Racial/Ethnic disparities in the PrEP Care Continuum in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2021 Apr 19. pii: 00126334-900000000-95894.
    >> Share

  407. HANS L, von Allmen N, Edelmann A, Hofmann J, et al
    Early diagnosis of HIV-1 and HIV-2 using cobas HIV-1/HIV-2 Qualitative, a novel qualitative nucleic acid amplification test for plasma, serum and dried blood spot specimens.
    J Acquir Immune Defic Syndr. 2021 Apr 19. pii: 00126334-900000000-95893.
    >> Share

  408. CRANE HM, Nance RM, Avoundjian T, Harding BN, et al
    Types of Stroke Among People Living With HIV in the United States.
    J Acquir Immune Defic Syndr. 2021;86:568-578.
    >> Share

  409. MEHROTRA ML, Westmoreland DA, Patel VV, Hojilla JC, et al
    Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV.
    J Acquir Immune Defic Syndr. 2021;86:e118-e125.
    >> Share

  410. VALENTE PK, Biello KB, Edeza A, Klasko-Foster L, et al
    Psychosocial Problems and Vulnerability to HIV in a Multi-City Prospective Cohort of Young Transgender Women in the United States: A Structural Equation Modeling Study.
    J Acquir Immune Defic Syndr. 2021;86:544-551.
    >> Share

  411. CHAS J, Bauer R, Larabi IA, Peytavin G, et al
    Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial.
    J Acquir Immune Defic Syndr. 2021;86:552-561.
    >> Share

  412. FREEMAN EE, Semeere A, McMahon DE, Byakwaga H, et al
    Beyond T Staging in the "Treat All" Era: Severity and Heterogeneity of Kaposi's Sarcoma in East Africa.
    J Acquir Immune Defic Syndr. 2021 Apr 14. pii: 00126334-900000000-95895.
    >> Share

  413. SUMARI-DE BOER M, Ngowi KM, Sonda T, Pima FM, et al
    Effect of Digital Adherence Tools on adherence to antiretroviral treatment among adults living with HIV in Kilimanjaro, Tanzania: a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Apr 10. pii: 00126334-900000000-95898.
    >> Share

  414. MISHRA A, Mshweshwe-Pakela N, Kubeka G, Hansoti B, et al
    Systems analysis to increase HIV testing delivery and HIV diagnosis in primary care clinics in South Africa.
    J Acquir Immune Defic Syndr. 2021 Apr 5. pii: 00126334-900000000-95899.
    >> Share

  415. SINGHVI DG, Nouraie M, Kessinger C, McMahon DK, et al
    Association between Pain, Pulmonary Function, and Respiratory Symptoms in People with HIV.
    J Acquir Immune Defic Syndr. 2021 Apr 5. pii: 00126334-900000000-95897.
    >> Share

  416. HSIEH SM, Pan SC, Huang YS, Chang SC, et al
    Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study.
    J Acquir Immune Defic Syndr. 2021;86:500-508.
    >> Share

  417. YIGIT I, Bayramoglu Y, Weiser SD, Johnson MO, et al
    Disclosure Concerns and Viral Suppression in People Newly Initiating HIV Care: The Role of Internalized HIV Stigma.
    J Acquir Immune Defic Syndr. 2021;86:406-412.
    >> Share

  418. BOSSARD C, Schramm B, Wanjala S, Jain L, et al
    High prevalence of NRTI and NNRTI drug resistance among ART-experienced, hospitalized inpatients.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95902.
    >> Share

  419. BAVINTON BR, Vaccher S, Jin F, Prestage GP, et al
    High levels of prevention-effective adherence to HIV pre-exposure prophylaxis (PrEP): An analysis of sub-study data from the EPIC-NSW trial.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95901.
    >> Share

  420. PELUSO MJ, Dee L, Taylor J, Campbell DM, et al
    SARS-CoV-2 vaccination in the context of ongoing HIV cure-related research studies.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95900.
    >> Share

    March 2021
  421. KHOSROPOUR CM, Dombrowski JC, Barbee LA, Kerani RP, et al
    Changing Patterns of Sexual Behavior and HIV/STI among Men who Have Sex with Men in Seattle, 2002 to 2018.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95906.
    >> Share

  422. JEWELL BL, Balzer LB, Clark TD, Charlebois ED, et al
    Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95905.
    >> Share

  423. CORNELISSE VJ, Traeger MW, Wright EJ, Murphy D, et al
    Low incidence of hepatitis C among a cohort of HIV-negative gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Melbourne, Australia, and the contribution of sexual transmission.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95904.
    >> Share

  424. OKERE NE, Lennox L, Urlings L, Ford N, et al
    Exploring sustainability in the era of differentiated HIV service delivery in Sub-Saharan Africa: A systematic review.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95903.
    >> Share

  425. SHIAU S, Cantos A, Ramon CV, Shen Y, et al
    Epigenetic age in young African American adults with perinatally-acquired HIV.
    J Acquir Immune Defic Syndr. 2021 Mar 18. pii: 00126334-900000000-95907.
    >> Share

  426. HINES JZ, Sachathep K, Pals S, Davis SM, et al
    HIV incidence by male circumcision status from the population-based HIV impact assessment (PHIA) surveys-eight sub-Saharan African countries, 2015-2017.
    J Acquir Immune Defic Syndr. 2021 Mar 16. pii: 00126334-900000000-95908.
    >> Share

  427. CHAN PA, Nunn A, Van Den Berg JJ, Cormier K, et al
    A randomized trial of a brief behavioral intervention for PrEP uptake among men who have sex with men at increased risk for HIV infection.
    J Acquir Immune Defic Syndr. 2021 Mar 15. pii: 00126334-900000000-95909.
    >> Share


  428. Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation: Erratum.
    J Acquir Immune Defic Syndr. 2021;86:387.
    >> Share

  429. PLUZNIK JA, Nijhawan AE, Spaulding AC
    Does Anything Work? Improving HIV Care Engagement for Individuals Transitioning out of Correctional Settings.
    J Acquir Immune Defic Syndr. 2021;86:286-287.
    >> Share

  430. COOLEY SA, Navid J, Wisch JK, Boerwinkle A, et al
    Relationships between Viral Load, Neuroimaging and Neuropsychological Performance in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95915.
    >> Share

  431. BAKER Z, Javanbacht M, Moore J, Brosnan H, et al
    A qualitative study on the acceptability of and adherence to a vaginal ring for HIV prophylaxis among adolescent girls.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95914.
    >> Share

  432. SILHOL R, Geidelberg L, Mitchell KM, Mishra S, et al
    Assessing the potential impact of disruptions due to COVID-19 on HIV among key and lower-risk populations in the largest cities of Cameroon and Benin.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95920.
    >> Share

  433. LEVY ME, Agopian A, Magnus M, Rawls A, et al
    Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM in the District of Columbia?
    J Acquir Immune Defic Syndr. 2021;86:e80-e82.
    >> Share

    February 2021
  434. EDELMAN EJ, Gan G, Dziura J, Esserman D, et al
    Readiness to provide medications for opioid, alcohol and tobacco use disorder in HIV clinics: A multi-site mixed-methods formative evaluation.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95919.
    >> Share

  435. SOMERVILLE K, Jenkins CA, Carlucci JG, Person AK, et al
    Outcomes After Second-Line Antiretroviral Therapy in Children Living with HIV in Latin America.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95918.
    >> Share

  436. BATHER JR, Williams PL, Broadwell C, Smith R, et al
    Racial/Ethnic Disparities in Longitudinal Emotional-Behavioral Functioning Among Youth Born to Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95917.
    >> Share

  437. JANULIS P, Goodreau SM, Birkett M, Phillips G 2nd, et al
    Temporal variation in one-time partnership rates among young men who have sex with men and transgender women.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95916.
    >> Share

  438. ERLY SJ, Naismith K, Kerani R, Buskin SE, et al
    Predictive Value of Time-Space Clusters for HIV Transmission in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95923.
    >> Share

  439. BHUSHAN NL, Stoner MCD, Twine R, Kahn K, et al
    Community Space, Community Groups, and Incident HIV Infection Among Adolescent Girls and Young Women in Rural South Africa: A Longitudinal Analysis of HIV Prevention Trials Network 068 Data.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95922.
    >> Share

  440. TAMARGO JA, Martin HR, Diaz-Martinez J, Trepka MJ, et al
    COVID-19 Testing and The Impact of The Pandemic on The Miami Adult Studies on HIV (MASH) Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95921.
    >> Share

  441. BRUXVOORT KJ, Schumacher CM, Towner W, Jones J, et al
    Referral linkage to pre-exposure prophylaxis (PrEP) care and persistence on PrEP in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95928.
    >> Share

  442. NEARY J, Wagner AD, Omondi V, Otieno V, et al
    Male caregiver barriers to HIV index-case testing of untested children.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95927.
    >> Share

  443. TAGGART T, Mayer KH, Vermund SH, Huang S, et al
    Interaction of religion/spirituality with internalized HIV stigma, depression, alcohol use, and sexual risk among Black men who have sex with men: The six city HPTN 061 study.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95926.
    >> Share

  444. DRIVSHOLM N, Knudsen AD, Faurholt-Jepsen M, Midttun O, et al
    Alterations in the kynurenine pathway of tryptophan metabolism are associated with depression in people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95925.
    >> Share

  445. MONTGOMERY ET, Browne E, Atujuna M, Boeri M, et al
    Long-acting injection and implant preferences and trade-offs for HIV prevention among South African male youth.
    J Acquir Immune Defic Syndr. 2021 Feb 22. pii: 00126334-900000000-95924.
    >> Share

  446. KUMAR P, Johnson M, Molina JM, Rizzardini G, et al
    Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95929.
    >> Share

  447. EJIMA K, Koizumi Y, Yamamoto N, Rosenberg M, et al
    HIV testing by public health centers and municipalities and new HIV cases during the COVID-19 pandemic in Japan.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95932.
    >> Share

  448. KELLY SG, Wu K, Tassiopoulos K, Erlandson KM, et al
    Incorporating frailty into the Pooled Cohort Equations to predict cardiovascular disease among persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95931.
    >> Share

  449. CINDI Z, Maartens G, Bradford Y, Venter F, et al
    Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir- and Tenofovir-containing Regimens.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95930.
    >> Share

  450. NOWAK RG, Liska TA, Bentzen SM, Kim E, et al
    Herpes Simplex Virus Type-2 shedding and genital ulcers during early HIV in Zimbabwean women.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95936.
    >> Share

  451. TRUONG HM, Fatch R, McFarland W, Raymond HF, et al
    HIV Prevention Responsibility Beliefs Among Men Who Have Sex with Men in the PrEP Era.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95935.
    >> Share

  452. VAN WYK J, Ait-Khaled M, Santos J, Scholten S, et al
    Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95934.
    >> Share

  453. KOHN JN, Loop MS, Kim-Chang JJ, Garvie PA, et al
    Trajectories of depressive symptoms, neurocognitive function and viral suppression with antiretroviral therapy among youth with HIV over 36 months.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95933.
    >> Share

  454. NIJHAWAN AE, Mathews WC, Raifman J, Fleming J, et al
    Hospitalization rates among persons with HIV who gained Medicaid or private insurance after the Affordable Care Act in 2014.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95945.
    >> Share

  455. MGODI NM, Takuva S, Edupuganti S, Karuna S, et al
    A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa: baseline findings.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95944.
    >> Share

  456. PALEFSKY JM, Poongulali S, Lensing S, Lee J, et al
    AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent vaccine in Indian Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95943.
    >> Share

  457. PRICE JT, Vwalika B, Edwards JK, Cole SR, et al
    Maternal HIV infection and spontaneous versus provider-initiated preterm birth in an urban Zambian cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95942.
    >> Share

  458. HUANG SH, Huang WC, Lin SW, Chuang YC, et al
    Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95941.
    >> Share

  459. PELCHEN-MATTHEWS A, Borges AH, Reekie J, Rasmussen LD, et al
    Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95940.
    >> Share

  460. EDUPUGANTI S, Mgodi N, Karuna ST, Andrew P, et al
    Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95939.
    >> Share

  461. CACHAY ER, Torriani FJ, Hill L, Rajagopal A, et al
    HCV knowledge and Recent Diagnosis Affect HCV Treatment Willingness in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95938.
    >> Share

  462. VERA JH, Eftychiou N, Schuerer M, Rullmann M, et al
    CLINICAL UTILITY OF beta-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95937.
    >> Share

  463. FARAHANI M, Radin E, Saito S, Sachathep K, et al
    Population Viral Load, Viremia and Recent HIV-1 Infections: Findings from Population-based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021 Feb 5. pii: 00126334-900000000-95947.
    >> Share

  464. SHARMA A, Hoover DR, Shi Q, Gustafson DR, et al
    High Frequency of Recurrent Falls among Pre-frail and Frail Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95950.
    >> Share

  465. PAGKAS-BATHER J, Khosropour CM, Golden MR, Thibault C, et al
    Population-level Effectiveness of HIV pre-exposure prophylaxis among MSM and Transgender Persons with Bacterial Sexually Transmitted Infections.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95949.
    >> Share

  466. PATEL VV, Felsen UR, Fisher M, Fazzari MJ, et al
    Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    J Acquir Immune Defic Syndr. 2021;86:224-230.
    >> Share

  467. MUCCINI C, Crowell TA, Pinyakorn S, Kroon E, et al
    Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;86:219-223.
    >> Share

  468. CRANE HM, Nance RM, Whitney BM, Heckbert SR, et al
    Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
    J Acquir Immune Defic Syndr. 2021;86:208-212.
    >> Share

  469. CHOW EPF, Hocking JS, Ong JJ, Phillips TR, et al
    Brief Report: Changes in PrEP Use, Sexual Practice, and Use of Face Mask During Sex Among MSM During the Second Wave of COVID-19 in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2021;86:153-156.
    >> Share

    January 2021
  470. SABERI P, Ming K, Hojilla JC, Scott HM, et al
    HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive HIV PrEP intervention can avert loss of HIV prevention coverage during a global pandemic.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95952.
    >> Share

  471. WAIRIMU F, Ward NC, Liu Y, Dwivedi G, et al
    Cardiac transplantation in HIV positive patients: a narrative review.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95951.
    >> Share

  472. TIEN-HUAN L, Ismael FC, Suzue S, Rommel B, et al
    Evaluating Nonresponse Weighting Adjustment for the Population-Based HIV Impact Assessments Surveys: On Incorporating Survey Outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95955.
    >> Share

  473. JOHNSON KA, Chen MJ, Kohn R, Sachdev D, et al
    Acute HIV at the time of initiation of Pre or Post Exposure Prophylaxis: Impact on drug-resistance and clinical outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95954.
    >> Share

  474. PAMPATI S, Emrick K, Siegler AJ, Jones J, et al
    Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95953.
    >> Share

  475. VAN DER HEIJDEN WA, Wan J, Van de Wijer L, Jaeger M, et al
    Plasmatic coagulation capacity correlates with inflammation and abacavir-use during chronic HIV-infection.
    J Acquir Immune Defic Syndr. 2021 Jan 26. pii: 00126334-900000000-95956.
    >> Share

  476. GOODRICH S, Siika A, Mwangi A, Nyambura M, et al
    Development, assessment and outcomes of a community-based model of anti-retroviral care in western Kenya through a cluster-randomized control trial.
    J Acquir Immune Defic Syndr. 2021 Jan 21. pii: 00126334-900000000-95957.
    >> Share

  477. ONGOLLY FK, Dolla A, Ngure K, Irungu EM, et al
    "I just decided to stop: " Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95963.
    >> Share

  478. COBURN SB, Shiels M, Silverberg M, Horberg M, et al
    Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95962.
    >> Share

  479. ZHANG L, Abohashem S, Osborne MT, Naddaf N, et al
    Lower Socioeconomic Status Associates with Greater Systemic and Arterial Inflammation in HIV.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95961.
    >> Share

  480. CHEN Y, Gao Y, Zhou Y, Li X, et al
    Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-analysis of Prospective Studies.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95958.
    >> Share

  481. BUSZA J, Hensen B, Birdthistle I, Chabata ST, et al
    What's in a name? A mixed method study on how young women who sell sex characterise male partners and their use of condoms.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95964.
    >> Share

  482. CRABLE EL, Blue TR, McKenzie M, Rich JD, et al
    Effect of case management on HIV outcomes for community corrections population: Results of an 18-month randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95960.
    >> Share

  483. MUCCINI C, Galli L, Poli A, Chiurlo M, et al
    Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95959.
    >> Share

  484. RANA MN, Kim CH, Sullivan CE, Longenecker CT, et al
    Performance of Methods to Estimate Low-Density Lipoprotein Cholesterol in Women with and without HIV infection.
    J Acquir Immune Defic Syndr. 2021 Jan 18. pii: 00126334-900000000-95966.
    >> Share

  485. BIEN-GUND CH, Ho JI, Bair EF, Marcus N, et al
    Financial incentives and real-time adherence monitoring to promote daily adherence to HIV treatment and viral suppression among people living with HIV: a pilot study.
    J Acquir Immune Defic Syndr. 2021 Jan 15. pii: 00126334-900000000-95965.
    >> Share

  486. DIRAJLAL-FARGO S, Williams PL, Broadwell C, McFARLAND EJ, et al
    Youth living with perinatally-acquired HIV have lower physical activity levels as they age compared to HIV-exposed uninfected youth.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95968.
    >> Share

  487. RAO A, Rucinski K, Jarrett B, Ackerman B, et al
    Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95967.
    >> Share

  488. GATHE JC, Hardwicke RL, Garcia F, Weinheimer S, et al
    Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1: A Phase 2a study.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  489. MEGGI B, Bollinger T, Zitha A, Mudenyanga C, et al
    Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  490. HENRY RT, Jiamsakul A, Law M, Losso M, et al
    Factors Associated With And Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  491. SPRING S, O'Bryan J, McMahon J, Woolley I, et al
    Acceptability of Injectable Antiretroviral Therapy in Australian Travelers With HIV.
    J Acquir Immune Defic Syndr. 2021;86:e13-e15.
    >> Share

  492. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
    J Acquir Immune Defic Syndr. 2021;86:119-127.
    >> Share

  493. DUNN D, Price H, Vudriko T, Kityo C, et al
    New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
    J Acquir Immune Defic Syndr. 2021;86:98-103.
    >> Share

  494. ELLSWORTH GB, Burke LA, Wells MT, Mishra S, et al
    Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2021;86:73-80.
    >> Share

  495. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.
    J Acquir Immune Defic Syndr. 2021;86:46-55.
    >> Share

  496. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago.
    J Acquir Immune Defic Syndr. 2021;86:31-37.
    >> Share

  497. PAHWA S, Deeks S, Zou S, Tomitch N, et al
    NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.
    J Acquir Immune Defic Syndr. 2021;86:11-18.
    >> Share

    December 2020
  498. OLALI AZ, Sharma A, Shi Q, Hoover DR, et al
    Change in circulating undercarboxylated osteocalcin (ucOCN) is associated with fat accumulation in HIV-seropositive women.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  499. MCQUILLAN GM, Kruszon-Moran D, Gu Q, Masciotra S, et al
    Prevalence and trends in HIV infection and testing among adults in the United States: The National Health and Nutrition Examination Surveys, 1999-2018.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  500. MOSKOWITZ DA, Moran KO, Matson M, Alvarado-Avila A, et al
    The PrEP cascade in a national cohort of adolescent men who have sex with men.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  501. FELNER JK, Mittal ML, Hoenigl M, Amico KR, et al
    Constructions of HIV Risk Among a Diverse Sample of HIV-Negative Young Men who have Sex with Men who are Repeat Testers.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  502. MOHAREB AM, Patel AV, Laeyendecker OB, Toerper MF, et al
    The HIV screening cascade: current Emergency Department-based screening strategies leave many patients with HIV undiagnosed.
    J Acquir Immune Defic Syndr. 2020 Dec 28. doi: 10.1097/QAI.0000000000002609.
    >> Share

  503. MULATU MS, Wang G, Song W, Keatley J, et al
    HIV Testing, Diagnosis of HIV Infection, Linkage to Medical Care, and Interview for Partner Services among Transgender Persons - United States, 2012-2017.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  504. MOSHIRI N, Smith DM, Mirarab S
    HIV Care Prioritization using Phylogenetic Branch Length.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  505. O'HALLORAN JA, Wang K, Spence AB, Williams DW, et al
    Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women with HIV.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  506. LEDERMAN MM
    AIDS in the Heartland- Hemophilia was the Harbinger of Things to Come.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  507. BLAIR CS, Lake JE, Passaro RC, Chavez-Gomez S, et al
    HIV-1 Seroconversion is Not Associated with Prolonged Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  508. PETOUMENOS K, Kuwanda L, Ryom L, Mocroft A, et al
    Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  509. WEISER JK, Tie Y, Beer L, Fanfair RN, et al
    Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  510. KATZ IT, Musinguzi N, Bell K, Cross A, et al
    The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era - A Multisite Cohort Study.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  511. SAMRI A, Chalouni M, Blanco J, Behrens G, et al
    Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  512. TOLENTINO A, Amaral S, Souza LS, Zeballos D, et al
    Frequency of falls and associated risk factors in people living with HIV: a systematic review with meta-analysis and meta-regression.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  513. STEK C, Buyze J, Menten J, Schutz C, et al
    Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  514. CHOW EPF, Ong JJ, Denham I, Fairley CK, et al
    HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  515. MALLARINO-HAEGER C, Abebe KZ, Jackson EK, Zyhowski A, et al
    Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;85:665-669.
    >> Share

  516. GINGRICH D, Deitchman AN, Kantor A, Huang L, et al
    Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:651-658.
    >> Share

  517. HSIEH YL, Jahn A, Menzies NA, Yaesoubi R, et al
    Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
    J Acquir Immune Defic Syndr. 2020;85:643-650.
    >> Share

  518. TORGERSEN J, Kallan MJ, Carbonari DM, Park LS, et al
    Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.
    J Acquir Immune Defic Syndr. 2020;85:530-534.
    >> Share

  519. LINNEMAYR S, Barreras JL, Izenberg M, Brooks RA, et al
    Longitudinal Assessment of Changes in Mental and Sexual Health Outcomes Due to COVID-19 Among Latinx SMM and TGW.
    J Acquir Immune Defic Syndr. 2020;85:e90-e92.
    >> Share

  520. PEREZ-VALERO I, Llibre JM, Castagna A, Pulido F, et al
    Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
    J Acquir Immune Defic Syndr. 2020 Dec 10. doi: 10.1097/QAI.0000000000002595.
    >> Share

  521. ELLIS RJ, Iudicello J, Sun-Suslow N, Grelotti D, et al
    Social isolation is linked to inflammation in aging people with HIV and uninfected individuals.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002596.
    >> Share

  522. ABRAMS EJ, Mofenson LM, Pozniak A, Lockman S, et al
    Enhanced and timely investigation of ARVs for use in pregnant women.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002597.
    >> Share

  523. NAIDOO K, Mansoor LE, Katz AW, Garcia M, et al
    Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial.
    J Acquir Immune Defic Syndr. 2020 Dec 3. doi: 10.1097/QAI.0000000000002590.
    >> Share

  524. SINHA A, Mystakelis H, Rivera AS, Manion M, et al
    Association of Low CD4/CD8 Ratio With Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2020;85:e73-e76.
    >> Share

  525. MANSERGH G, Stephenson R, Hirshfield S, Sullivan P, et al
    Understanding HIV Sexual Protection and Its Association With Substance Use During Sex Among MSM in an Era of Multiple Primary Prevention Products.
    J Acquir Immune Defic Syndr. 2020;85:e67.
    >> Share

  526. POTEAT TC, Reisner SL, Miller M, Wirtz AL, et al
    Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.
    J Acquir Immune Defic Syndr. 2020;85:e67-e69.
    >> Share

  527. THORBALL CW, Borghesi A, Bachmann N, Von Siebenthal C, et al
    Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020;85:517-524.
    >> Share

  528. LUCAS GM, Atta MG, Zook K, Vaidya D, et al
    Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.
    J Acquir Immune Defic Syndr. 2020;85:e58-e66.
    >> Share

  529. RODRIGUEZ VJ, Zegarac M, La Barrie DL, Parrish MS, et al
    Validation of the Bayley Infant Neurodevelopmental Screener Among HIV-Exposed Infants in Rural South Africa.
    J Acquir Immune Defic Syndr. 2020;85:507-516.
    >> Share

  530. RIZZARDINI G, Overton ET, Orkin C, Swindells S, et al
    Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
    J Acquir Immune Defic Syndr. 2020;85:498-506.
    >> Share

  531. HAN WM, Bijker R, Chandrasekaran E, Pujari S, et al
    Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
    J Acquir Immune Defic Syndr. 2020;85:489-497.
    >> Share

  532. MANN SC, Morrow M, Coyle RP, Coleman SS, et al
    Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
    J Acquir Immune Defic Syndr. 2020;85:483-488.
    >> Share

  533. BALLIVIAN J, Alcaide ML, Cecchini D, Jones DL, et al
    Impact of COVID-19-Related Stress and Lockdown on Mental Health Among People Living With HIV in Argentina.
    J Acquir Immune Defic Syndr. 2020;85:475-482.
    >> Share

  534. BK K, Tiwari S, Chhapola V, Debnath E, et al
    Brief Report: Subclinical Kidney Dysfunction in HIV-Infected Children: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2020;85:470-474.
    >> Share

  535. MCCLEAN M, Buzkova P, Budoff M, Estrella M, et al
    Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:466-469.
    >> Share

  536. MILLER L, Morar N, Kapiga S, Ramjee G, et al
    Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    J Acquir Immune Defic Syndr. 2020;85:458-465.
    >> Share

  537. HEBEL S, Kahn-Woods E, Malone-Thomas S, McNeese M, et al
    Brief Report: Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings.
    J Acquir Immune Defic Syndr. 2020;85:454-457.
    >> Share

  538. BOYD AT, Odume B, Sidibe K, Onotu D, et al
    Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.
    J Acquir Immune Defic Syndr. 2020;85:450-453.
    >> Share

  539. CONTE M, Eshun-Wilson I, Geng E, Imbert E, et al
    Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment.
    J Acquir Immune Defic Syndr. 2020;85:444-449.
    >> Share

  540. DEAN LT, Nonyane BAS, Ugoji C, Visvanathan K, et al
    Economic Burden Among Gay, Bisexual, and Other Men Who Have Sex With Men Living With HIV or Living Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020;85:436-443.
    >> Share

  541. CHAPIN-BARDALES J, Johnson Jones ML, Kirkcaldy RD, Bernstein KT, et al
    Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States-National HIV Behavioral Surveillance, 5 US Cities, 2017.
    J Acquir Immune Defic Syndr. 2020;85:430-435.
    >> Share

  542. MOORE JR, Donnell DJ, Boily MC, Mitchell KM, et al
    Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.
    J Acquir Immune Defic Syndr. 2020;85:423-429.
    >> Share

  543. JEAN LOUIS F, Domercant JW, Ignacio C, Gianella S, et al
    High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    J Acquir Immune Defic Syndr. 2020;85:416-422.
    >> Share

  544. XIA Y, Greenwald ZR, Milwid RM, Trottier C, et al
    Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montreal (Canada).
    J Acquir Immune Defic Syndr. 2020;85:408-415.
    >> Share

  545. DE ANDA S, Njoroge A, Njuguna I, Dunbar MD, et al
    Predictors of First-Time and Repeat HIV Testing Among HIV-Positive Individuals in Kenya.
    J Acquir Immune Defic Syndr. 2020;85:399-407.
    >> Share

  546. MOORE M, Boily MC, Mitchell KM, Donnell DD, et al
    Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.
    J Acquir Immune Defic Syndr. 2020;85:395-398.
    >> Share

  547. BRUMMEL SS, Taha TE, Angelidou KN, Saidi F, et al
    Impact of Antiretroviral Therapy on Maternal Health after Cessation of Breastfeeding.
    J Acquir Immune Defic Syndr. 2020 Dec 1. doi: 10.1097/QAI.0000000000002586.
    >> Share

  548. LEFEBVRE M, Walencik A, Allavena C, Billaud E, et al
    Rate of DRESS Syndrome With Raltegravir and Role of the HLA-B*53: 01 Allele.
    J Acquir Immune Defic Syndr. 2020;85:e77-e80.
    >> Share

    November 2020
  549. HUANG YS, Cheng CY, Liou BH, Lu PL, et al
    Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment in HIV/HBV-coinfected patients.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002589.
    >> Share

  550. MIN HAN W, Ueaphongsukkit T, Chattranukulchai P, Siwamogsatham S, et al
    Incident liver cirrhosis, associated factors and cardiovascular disease risks among people living with HIV: a longitudinal study.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002585.
    >> Share

  551. MAZAHERI-TEHRANI E, Mohraz M, Nasi M, Chester J, et al
    NLRP3 and IL-1beta gene expression is elevated in monocytes from HIV treated patients with neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002588.
    >> Share

  552. PINTYE J, O'Malley G, Kinuthia J, Abuna F, et al
    Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002587.
    >> Share

  553. CELERINO DA SILVA R, Segat L, Kuhn L, Bogo Chies JA, et al
    Association of single nucleotide polymorphisms in HLA-C and ZNRD1 genes with HIV-1 mother to child transmission in Zambia population.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002584.
    >> Share

  554. UNG MJ, Fairley CK, Martin SJ, Ong JJ, et al
    Pre-exposure Prophylaxis for HIV - an opportunity for the global control of sexually transmitted infections.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002582.
    >> Share

  555. PATHMANATHAN I, Nelson R, de Louvado A, Thompson R, et al
    High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chokwe Health Demographic Surveillance System, Mozambique, 2014-2019.
    J Acquir Immune Defic Syndr. 2020 Nov 21. doi: 10.1097/QAI.0000000000002583.
    >> Share

  556. SILHOL R, Baral S, Bowring AL, Mukandavire C, et al
    Quantifying the evolving contribution of HIV interventions and key populations to the HIV epidemic in Yaounde, Cameroon.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002580.
    >> Share

  557. HAMILL MM, Hu F, Kokogho A, Shoyemi E, et al
    Factors Associated with Condom Failure in a Longitudinal Cohort of Men who have Sex with Men and Transgender Women in Abuja and Lagos, Nigeria.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002559.
    >> Share

  558. OLIVEIRA VH, Borsari AL, CArdenas JDG, Alves Junior CM, et al
    Low Agreement Between Initial and Revised European Consensus on Definition and Diagnosis of Sarcopenia Applied to People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002576.
    >> Share

  559. VAN BILSEN WPH, Zimmermann HML, Boyd A, Coyer L, et al
    Sexual behavior and its determinants during COVID-19 restrictions among men who have sex with men in Amsterdam.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002581.
    >> Share

  560. SEKIZIYIVU AB, Bancroft E, Rodriguez EM, Sendagala S, et al
    Task shifting for initiation and monitoring of antiretroviral therapy for HIV-infected adults in Uganda: The SHARE Trial.
    J Acquir Immune Defic Syndr. 2020 Nov 17. doi: 10.1097/QAI.0000000000002567.
    >> Share

  561. MACGIBBON J, Lea T, Ellard J, Murphy D, et al
    Access to subsidised healthcare affects HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia: results of national surveys 2013-19.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002572.
    >> Share

  562. ABDO M, Langan SJ, MaWhinney S, Sun J, et al
    The Effect of Statin Therapy on Age-Associated Changes in Physical Function Among Men With and Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002579.
    >> Share

  563. BOGART LM, Ojikutu BO, Tyagi K, Klein DJ, et al
    COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002570.
    >> Share

  564. MULATO A, Acosta R, Chang S, Martin R, et al
    Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002562.
    >> Share

  565. SCHNITTMAN SR, Zepf R, Cocohoba J, Sears D, et al
    Heplisav-B Seroprotection in People with HIV: A Single-Center Experience.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002573.
    >> Share

  566. ATKINS K, Rucinski K, Mudavanhu M, Holmes L, et al
    Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002569.
    >> Share

  567. GOSWAMI S, Hu X, Chen Q, Qiu J, et al
    Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T cells: Identification of a Novel Anti-Viral MicroRNA.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002565.
    >> Share

  568. CASALE M, Cluver L, Boyes M, Toska E, et al
    Bullying and ART non-adherence among South African adolescents living with HIV: effects, risk and protective factors.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002574.
    >> Share

  569. JOHNSON LM, Green HD Jr, Koch B, Stockman JK, et al
    Role of social networks and social norms in future PrEP use in a racially-diverse sample of at-risk women and members of their social networks.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002571.
    >> Share

  570. BERES LK, Schwartz S, Simbeza S, McGready J, et al
    Patterns and Predictors of Incident Return to HIV Care Among Traced, Disengaged Patients in Zambia: Analysis of a prospective cohort.
    J Acquir Immune Defic Syndr. 2020 Nov 4. doi: 10.1097/QAI.0000000000002554.
    >> Share

  571. BULTERYS MA, Sharma M, Mugwanya K, Stein G, et al
    Correlates of HIV status non-disclosure by pregnant women living with HIV to their male partners in Uganda: a cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002566.
    >> Share

  572. PIZZIRUSSO M, Carrion-Park C, Clark US, Gonzalez J, et al
    Physical and mental health screening in a New York City HIV cohort during the COVID-19 pandemic: A preliminary report.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002564.
    >> Share

  573. MAYER ME, White E, Montano MA, Lama JR, et al
    Sexual Behavior among Men Who Have Sex with Men: the Need for More Targeted Outreach to Men Who Also Have Sex with Cisgender Women.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002568.
    >> Share

  574. MIMIAGA MJ, Hughto JMW, Klasko-Foster L, Jin H, et al
    Substance use, mental health problems, and physical and sexual violence additively increase HIV risk between male sex workers and their male clients in Northeastern United States.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002563.
    >> Share

  575. SUMMERS NA, Lahiri CD, Angert CD, Aldredge A, et al
    Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.
    J Acquir Immune Defic Syndr. 2020;85:355-362.
    >> Share

  576. BEBELL LM, Siedner MJ, Ngonzi J, Le MH, et al
    Brief Report: Chronic Placental Inflammation Among Women Living With HIV in Uganda.
    J Acquir Immune Defic Syndr. 2020;85:320-324.
    >> Share

    October 2020
  577. ZHAO H, Li J, Li S, Wang Y, et al
    Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002561.
    >> Share

  578. CHAHINE A, Koru-Sengul T, Feaster DJ, Dilworth SE, et al
    Blue Monday: Co-Occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002560.
    >> Share

  579. KUNIHOLM MH, Bramah-Lawani M, Fitzpatrick M, Nouraie M, et al
    Association of monocyte migration marker CD11b with pulmonary function in people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002544.
    >> Share

  580. ROTH AM, Tran NK, Felsher MA, Gadegbeku AB, et al
    Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE demonstration study.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002558.
    >> Share

  581. RUDERMAN SA, Crane HM, Nance RM, Whitney BM, et al
    Weight gain following antiretroviral therapy (ART) initiation in ART-naive people living with HIV in the current treatment era.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002556.
    >> Share

  582. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase Pre-Exposure Prophylaxis Uptake for HIV prevention: 55-week results from PrEPChicago.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002518.
    >> Share

  583. EHRENKRANZ P, Grimsrud A, Holmes CB, Preko P, et al
    Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002549.
    >> Share

  584. DAVIS SM, Habel MA, Pretorius C, Yu T, et al
    Modeling the Impact of Voluntary Medical Male Circumcision (VMMC) on Cervical Cancer in Uganda.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002552.
    >> Share

  585. TEIXEIRA DA SILVA D, Bouris A, Ramachandran A, Blocker O, et al
    Embedding a Linkage to Pre-Exposure Prophylaxis (PrEP) Care Intervention in Social Network Strategy and Partner Notification Services: Results from a Pilot Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002548.
    >> Share

  586. GOYAL R, Hu C, Klein PW, Hotchkiss J, et al
    DEVELOPMENT OF A MATHEMATICAL MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF THE RYAN WHITE HIV/AIDS PROGRAM.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002546.
    >> Share

  587. SRINIVASAN K, Heylen E, Raj T, Nyblade L, et al
    Reduction in stigma drivers partially mediates the effect of a stigma reduction intervention among nursing students in India: The DriSti cluster randomized controlled trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002543.
    >> Share

  588. HOOVER KW, Khalil GM, Cadwell BL, Rose CE, et al
    Benchmarks for HIV Testing: What is Needed to Achieve Universal Testing Coverage at U.S. Ambulatory Healthcare Facilities.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002553.
    >> Share

  589. GANESH P, Heller T, Chione B, Gumulira J, et al
    NEAR POINT OF CARE HIV VIRAL LOAD: TARGETED TESTING AT LARGE FACILITIES.
    J Acquir Immune Defic Syndr. 2020 Oct 21. doi: 10.1097/QAI.0000000000002555.
    >> Share

  590. GHARE SS, Chilton PM, Rao AV, Joshi-Barve S, et al
    Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002526.
    >> Share

  591. BRAUNSTEIN SL, Robbins RS, Ramaswamy C, Daskalakis D, et al
    DRUG OVERDOSE DEATHS AMONG PEOPLE WITH HIV IN NEW YORK CITY, 2007-2017.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002545.
    >> Share

  592. PHILLIPS TR, Fairley CK, Bradshaw FAChSHM CS, Hocking JS, et al
    Group sex among men who have sex with men in the era of PrEP: A cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002550.
    >> Share

  593. TRUONG HM, Mehrotra ML, Grant RM
    Seroadaptive Behaviors Varied among Geographically-Diverse iPrEx Participants.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002551.
    >> Share

  594. GOYAL R, Luca D, Klein P, Morris E, et al
    Cost-Effectiveness of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002547.
    >> Share

  595. GEIDELBERG L, Mitchell KM, Alary M, Mboup A, et al
    A mathematical model impact analysis of a real-life pre-exposure prophylaxis and treatment-as-prevention study among female sex workers in Cotonou, Benin.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002535.
    >> Share

  596. MODY A, Sikombe K, Beres LK, Simbeza S, et al
    Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002530.
    >> Share

  597. VERHEIJ E, Wit FW, Verboeket SO, Schim van der Loeff MF, et al
    Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002532.
    >> Share

  598. HU R, Yan H, Liu M, Tang L, et al
    Virologic and immunologic outcomes for HIV patients with coronavirus disease 2019.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002540.
    >> Share

  599. WOZNICA DM, Fernando NB, Bonomo EJ, Owczarzak J, et al
    Interventions to improve HIV care continuum outcomes among individuals released from prison or jail: Systematic literature review.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002523.
    >> Share

  600. AMELE S, Peters L, Rodger A, Lundgren J, et al
    Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002541.
    >> Share

  601. AFFI R, Gabillard D, Dunyach-Remy C, Ntakpe JB, et al
    0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002533.
    >> Share

  602. MCLAUGHLIN TA, Nizam A, Hayara FO, Ouma GS, et al
    Schistosoma mansoni infection is associated with a higher probability of tuberculosis disease in HIV-infected adults in Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002536.
    >> Share

  603. AGUILERA-ALONSO D, Sainz T, Jimenez DE Ory S, Bernardino I, et al
    Clinical, Immunological and Virological Outcomes among youths with perinatal HIV after Transition to Adult Units in Spain from 1997 to 2016.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002539.
    >> Share

  604. CALZA L, Bon I, Borderi M, Colangeli V, et al
    COVID-19 OUTCOMES IN PATIENTS WITH UNCONTROLLED HIV-1 INFECTION.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002537.
    >> Share

  605. ECKARD AR, Hughes HY, Hagood NL, O'Riordan MA, et al
    Fecal Calprotectin is Elevated in HIV and Related to Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002538.
    >> Share

  606. SACHDEV D, Mara E, Hsu L, Scheer S, et al
    COVID-19 Susceptibility and Outcomes among People Living with HIV in San Francisco.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002531.
    >> Share

  607. SHARMA M, Kariithi E, Kemunto E, Otieno G, et al
    High acceptability of assisted partner notification services among HIV-positive females in Kenya: Results from an ongoing implementation study.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002527.
    >> Share

  608. PETERS M, Margevicius S, Kityo C, Mirembe G, et al
    The Association of Kidney Disease with Abnormal Cardiac Structure and Function among Ugandans with HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002529.
    >> Share

  609. ALBAUGH NW, Nonyane BAS, Mmolawa L, Siwelana T, et al
    Proportion and predictors of adult TB contacts accepting HIV testing during an active TB case finding intervention in South Africa.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002509.
    >> Share

  610. HAMMOUD MA, Grulich A, Holt M, Maher L, et al
    Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002514.
    >> Share

  611. DE BAETSELIER I, Tsoumanis A, Florence E, Van den Berghe W, et al
    Did pre-exposure prophylaxis roll-out influence the epidemic of rectal lymphogranuloma venereum in Belgium? Results from the national surveillance system.
    J Acquir Immune Defic Syndr. 2020 Oct 6. doi: 10.1097/QAI.0000000000002524.
    >> Share

  612. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral interventions can mitigate adverse pregnancy outcomes among women conceiving on antiretroviral therapy (ART) and those initiated on ART during pregnancy: Findings from the MOTIVATE trial in southwestern Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002521.
    >> Share

  613. JIN H, Biello K, Garofalo R, Lurie M, et al
    Examining the longitudinal predictive relationship between HIV treatment outcomes and pre-exposure prophylaxis use by serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002522.
    >> Share

  614. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    INTEGRASE INHIBITORS USE AND CMV INFECTION PREDICT IMMUNE RECOVERY IN PEOPLE LIVING WITH HIV STARTING FIRST-LINE THERAPY.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002525.
    >> Share

  615. KAPITO-TEMBO AP, Bauleni A, Wesevich A, Ongubo D, et al
    Growth and neurodevelopment outcomes in HIV, tenofovir and efavirenz exposed breastfed infants in PMTCT Option B+ program in Malawi.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002515.
    >> Share

  616. STRATHDEE SA, Martin NK, Pitpitan EV, Stockman JK, et al
    What the HIV Pandemic Experience can Teach the U.S. about the COVID-19 Response.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002520.
    >> Share

  617. BHARTI AR, McCutchan JA, Umlauf A, Okwuegbuna OK, et al
    Asymptomatic Malaria Co-infection of HIV-infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood and Biomarkers of Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 1. doi: 10.1097/QAI.0000000000002516.
    >> Share

    September 2020
  618. HICKEY MD, Ayieko J, Kwarisiima D, Opel FJ, et al
    Improved Viral Suppression with Streamlined Care in the SEARCH Study.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002508.
    >> Share

  619. HARGREAVES JR, Pliakas T, Hoddinott G, Mainga T, et al
    HIV stigma and viral suppression among people living with HIV in the context of universal test and treat: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002504.
    >> Share

  620. WANGA V, Mackelprang RD, Thomas KK, Donnell D, et al
    Bacterial vaginosis and risk of HIV infection in the context of CD101 gene variation.
    J Acquir Immune Defic Syndr. 2020 Sep 18. doi: 10.1097/QAI.0000000000002505.
    >> Share

  621. WU L, Schumacher C, Chandran A, Fields E, et al
    Patterns of PrEP Retention among HIV Pre-Exposure Prophylaxis Users in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002506.
    >> Share

  622. THIVALAPILL N, Jasumback CL, Perry SH, Dlamini L, et al
    Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002512.
    >> Share

  623. AHRENSTORF G, Jablonka A, Ernst D, Bange FC, et al
    Improved prognosis of infection with M. genavense in immune compromized HIV patients after introduction of combined antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002513.
    >> Share

  624. VITELLI M, Mazelle H, Joncour AL, Amelot A, et al
    A Diagnosis Can Hide Another: The Value of Brain Biopsy in Neurological Lesion of HIV Patients.
    J Acquir Immune Defic Syndr. 2020 Sep 14. doi: 10.1097/QAI.0000000000002511.
    >> Share

    August 2020
  625. WANG L, Tan DHS, Mishra S
    Evidence of Nonrandom Mixing by Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2016 to 2018.
    J Acquir Immune Defic Syndr. 2020;84:e22-e23.
    >> Share

    July 2020
  626. GAO G, Wang A, Wang S, Qian F, et al
    A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002452.
    >> Share

  627. YAGER J, Castillo-Mancilla J, Ibrahim ME, Brooks KM, et al
    Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
    J Acquir Immune Defic Syndr. 2020;84:323-330.
    >> Share

  628. BOFFA JM, Fisher DA, Mayan MJ, Sauve RS, et al
    Effectiveness of Isoniazid Preventive Therapy to Reduce Tuberculosis Incidence in the Context of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;84:e14-e17.
    >> Share

  629. KASPER P, Phiri S, Chaweza T, Tweya H, et al
    Ambulatory Blood Pressure Monitoring in PLHIV in Malawi: Preliminary Findings.
    J Acquir Immune Defic Syndr. 2020;84:e11-e14.
    >> Share

    March 2020
  630. SPINELLI MA, Rodrigues WC, Wang G, Vincent M, et al
    HIGH ACCURACY OF A REAL-TIME URINE ANTIBODY-BASED TENOFOVIR POINT-OF-CARE TEST COMPARED TO LABORATORY-BASED ELISA IN DIVERSE POPULATIONS.
    J Acquir Immune Defic Syndr. 2020 Mar 10. doi: 10.1097/QAI.0000000000002322.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016